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ABSTRACT 
 
 
In use since the 1960s, polypropylene (PP) biomaterials are common in 
commercially available hernia meshes due to their high tensile strength, good flexibility, 
and chemical resistance. The in vivo environment is highly variable, exposing mesh 
implants to oxidizing species and mechanical strains caused by normal healing, tissue 
integration, and the immediate and chronic inflammatory responses. As a result, changes 
in mesh implant materials can occur in vivo, including morphological changes, chemical 
changes and mechanical changes. The broad objective of this dissertation was to explore 
mechanisms of material changes in polymeric mesh implants after in vivo exposure using 
experimental characterization and biological assessments.  
Biological assessments included mesh implants retrieved from patients after 
hernia repair surgery (mesh explants) to explore potential degradation mechanisms, 
specifically the impact of clinical characteristics for triggering material changes in pore 
size, surface chemistry, crystallinity and stiffness consistent with PP degradation. 
Development of an automated photogrammetric pore size and pore pattern recognition 
technique provided quantitative measurements of mesh pore size reduction and mesh 
contraction in mesh explants. Mesh class (pore size) was a factor affecting material 
changes in normalized crystallinity and reduced stiffness was observed in mesh explants 
from patients with infection.  
Experimental characterization included two studies. In vitro simulated PP mesh 
degradation explored specific mechanisms that potentially contributed to PP material 
changes. The synergistic effect of reactive oxygen species (ROS) associated with chronic 
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inflammation/infection and mechanical strains on PP mesh degradation was 
experimentally simulated. PP mesh degradation was observed in simulated ROS solutions 
made of 1.63M hydrogen peroxide (H2O2)/ 0.05M cobalt chloride (CoCl2), but the 
synergistic effect was not observed in the same simulated ROS solutions with applied 
low mechanical strains. A second experimental characterization involved surface 
modification of polymeric mesh implants for improved hernia mesh fixation with a 
hydrogel adhesive, called a “bio-adhesive mesh fixation system”. The “bio-adhesive 
mesh fixation system” combined two patented technologies of poly-glycidyl 
methacrylate/human serum albumin (PGMA/HSA) grafting and a poloxamine hydrogel 
adhesive. Its experimental maximum adhesive strength was approximately 2 times higher 
than that of unmodified mesh, which was achieved by mechanical interlock of the 
hydrogel tissue adhesive into the PP mesh pores and chemical bonding of the grafted 
albumin. 
Mesh explants retrieved from patients were valuable resources to explore material 
changes and the degradation mechanisms in highly variable in vivo conditions. 
Assessments of mesh explants were challenging due to the unknown mesh material 
properties before implantation and the uncontrolled nature of patient variables inherent in 
retrieval analysis. Compared to biological assessments, experimental characterization for 
in vitro simulation and mesh fixation system contributed to understanding mesh behavior 
in a controlled condition and building the foundation for predicting mesh behavior in 
physiological conditions. 
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PREFACE 
 
 
Broad Objective and Specific Aims 
 Surgical mesh is a medical device consisting of implantable polymeric materials. 
It is commonly used for surgical repair of abdominal hernia, which is a widespread health 
concern that occur secondary to weakened or damaged abdominal wall tissues. In use 
since the 1960s, polypropylene (PP) biomaterials are common in commercially available 
hernia meshes due to their high tensile strength, good flexibility, and chemical resistance. 
However, changes in mesh implant materials can occur in vivo, including morphological 
changes, chemical changes and mechanical changes. The in vivo environment is highly 
variable, exposing mesh implants to oxidizing species and applied mechanical strains 
caused by normal healing, tissue integration, and the immediate and chronic 
inflammatory responses. Mesh implants retrieved from patients after hernia repair 
surgery (hereafter, mesh explants) provide a unique source for investigating mesh 
material changes, specifically pore size, surface chemistry, crystallinity and stiffness. 
However, few studies have explored mechanisms that potentially contribute to material 
changes in vivo.  
 The broad objective of this dissertation is to explore mechanisms of material 
changes in polymeric mesh implants after in vivo exposure using experimental 
characterization and biological assessments. The following aims are addressed:   
Aim 1. Determine material changes of polymeric mesh explants and explore the 
mechanisms of material changes related to clinical factors. It is hypothesized that 1) 
 xv 
mesh explants have significant material changes compared to mesh implants before 
implantation; 2) mesh implants with small pore size, retrieved from infected patients, or 
implanted in intra-peritoneal location have significant material changes compared to 
mesh implants with large pore size, retrieved from non-infected patients, or implanted in 
extra-peritoneal location.  
Aim 2. Determine the effect of simulated oxidizing agents and applied mechanical 
strains on initiating polypropylene mesh degradation. It is hypothesized that the 
synergistic effect of oxidizing agents and mechanical strains significantly induces PP 
mesh degradation than the individual factors alone.  
Aim 3. Determine the effect of surface modification of polymeric mesh implants 
on fixation and compatibility with a hydrogel adhesive. It is hypothesized that the 
adhesive strength between the surface modified polymeric mesh implants and hydrogel 
adhesive is significantly higher than the adhesive strength between unmodified polymeric 
mesh implants and hydrogel adhesive. 
Aim 1 and Aim 2 address gaps for describing specific mechanisms that potentially 
contribute to mesh material changes after in vivo exposure using mesh explants and in 
vitro simulation. Aim 3 addresses a new technology combining two patented technologies 
that improves clinical outcomes of hernia mesh fixation.      
List of Studies 
Four studies (Figure P.1) are undertaken to address the three specific aims: 
 Chapter 2, titled “Pore Size Analysis of Explanted Surgical Mesh Using 
Photogrammetric Method” will address Aim 1 by comparing explanted mesh and pristine 
 xvi 
mesh and relating it to the pore pattern. It describes development of a photogrammetric 
method using image capture, image processing and image analysis to classify pore 
pattern and measure pore size and evaluates changes in pore size after physiological 
loading. 
 Chapter 3, titled “Analyzing Material Changes Consistent with Degradation of 
Explanted Surgical Mesh Related to Clinical Characteristics” will address Aim 1 by 
analyzing material changes of explanted PP mesh that center on potential degradation 
mechanisms and investigating clinical characteristics that may trigger the material 
changes consistent with PP degradation. 
 Chapter 4, titled “Understanding Mechanisms of Polypropylene Hernia Mesh 
Degradation Using Experimental Simulations” will address Aim 2 by defining a 
physiological continuum of reactive oxygen species (ROS) concentrations associated 
with chronic inflammation/infection and estimating the synergistic impact of ROS and 
mechanical strains on PP mesh degradation using in vitro simulation. 
 Chapter 5, titled “Surface Modification of Polypropylene Surgical Meshes for 
Improving Adhesion with Poloxamine Hydrogel Adhesive” will address Aim 3 by 
comparing two different surface modifications of PP mesh to improve the adhesive 
strength with poloxamine hydrogel adhesive by achieving both mechanical interlock and 
covalent bonds.  
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Figure P. 1 Organization of dissertation and relationship with each chapter. 
Explore Mechanisms of 
Material Changes in 
Polymeric Mesh Implants
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degradation mechanisms
Chapter 5. Surface modification 
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CHAPTER ONE 
 
MESH REGISTRY 
 
 
Mesh Types in Mesh Registry 
Hernia meshes in this dissertation were collected by a surgical team (Atrium 
Health, Charlotte, NC) through an established registry of mesh explants (MeshWatch) 
using a protocol approved by the Clemson University Institutional Review Board 
(IRB2014-161) (1). Meshes from consecutive patients undergoing revision hernia surgery 
from 2006 to 2014 were archived and stored in 10% formalin until analysis (2). Meshes 
from 2014 to 2018 were archived and fresh-frozen at -80° C until analysis. 
To date, there are 102 formalin fixed and 164 fresh frozen mesh explants of 
various types in the registry along with documentation of basic patient demographics and 
clinical history abstracted from available records. Details of mesh structure and type were 
cataloged for each explanted mesh using a pictorial “MeshWatch” atlas of known mesh 
types and knitted patterns characterized using gross assessment, optical microscopy, and 
digital imaging, as described in Chapter 2. Explanted mesh samples were biopsied and 
cleaned using defined tissue digestion methods to expose the mesh structure for material 
change characterization, as described in Chapter 3.  
The MeshWatch Atlas defines 9 known types of hernia meshes, including 
ComposixÔ E/X, ComposixÒ KugelÒ, ComposixÔ L/P, C -QURÒ , PhysiomeshÔ, 
Proleneâ Soft, Ultraproâ, VentralexÔ and VentralightÔ (Table 1.1). The expanded 
polytetrafluoroethylene (ePTFE) components of ComposixÔ E/X, ComposixÒ KugelÒ, 
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ComposixÔ L/P and VentralexÔ were removed for experimental characterization of 
material properties, as described in Chapter 2, Chapter 3, Chapter 4 and Chapter 5. The 
absorbable components of C-QURÒ, PhysiomeshÔ and VentralightÔ were washed by 
soaking in 0.01 M phosphate buffer solutions (PBS) at 37 °C on an orbital shaker for 12 
hours and rinsed by Millipore water, but they were unable to be completely removed. 
Pristine meshes in this dissertation are unused meshes removed from original packages 
within shelf life except ComposixÒ KugelÒ, which was recalled in 2006.  
Mesh Classification 
Most surgical meshes are manufactured using warp-knitting techniques to provide 
the flexibility and structural stability from the interlacing filament loops (3, 4). The loop 
structure patterns are normally repeatable because of the warp knitting machine, which 
makes identical lapping movements of the mesh filaments through guide holes attached 
to the same guide bar (5). The spaces between mesh filaments are mesh pores, allowing 
tissue ingrowth for hernia repair. Mesh pore size can be measured using image capture, 
image processing and image analysis to classify pore pattern and measure pore size, as 
described in Chapter 2. 
Meshes in MeshWatch are classified as Class I (large pore mesh with porosity > 
60% or an effective porosity > 0%), Class II (small pore mesh with porosity < 60% and 
without any effective porosity), and Class III (mesh with additional features) according to 
textile structures and a published classification scheme (6) (Table 1.1). The effective 
porosity is the pore size allowing tissue ingrowth instead of “bridging”, which occurs 
when the small pores are completely filled with inflammatory infiltrates or fibrotic scars 
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(7-10). The minimum pore size for effective porosity is 1 mm for PP mesh (11). Meshes 
with large pores facilitate tissue ingrowth (10), while meshes with small pores induce 
greater inflammatory response and increase abdominal wall stiffness (7-10). PP meshes 
combined with additional features are capable of reducing complications, such as tissue 
adhesion, foreign body reaction, chronic pain and infection. 
Mesh Crystallinity 
 PP is a semi-crystalline polymer with crystalline and amorphous regions. Its 
crystallinity affects mechanical (12) and chemical properties (13). PP having increased 
crystallinity results in increased stiffness (12). However, PP with higher crystallinity has 
reduced resistance to free radicals than lower crystallinity in case of gamma radiation 
(12). These radicals are trapped in the crystalline regions, resulting in chain scission or 
crosslinking and leading to increased brittleness (12).  
PP mesh crystallinity can be measured using differential scanning calorimetry 
(DSC), as described in Chapter 3 and Chapter 4. The crystallinity of the pristine PP 
meshes in MeshWatch ranges from 41.9% to 48.1% (Table 1.2), compared to referenced 
PP meshes with crystallinity of 40% to 57% (14-17). Meshes with absorbable layers are 
not included in Table 1.2. The crystallinity of pristine cleaning controls ranges from 
41.9% to 50.0%, as described in in Chapter 3. The crystalline regions disappear at the 
melting point, determined by the amount of crystallinity. The melting temperature of the 
pristine PP meshes in MeshWatch ranges from 164.5°C to 169.9 °C (Table 1.2), 
compared to a perfect isotactic PP with theoretical melting point of 171 °C (12). PP 
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without additives and with lower crystallinity leads to decreased melting temperature 
(Tm) (12). The crystallinity and Tm can be altered for PP with additives (18, 19).  
Mesh Stiffness 
 Mesh stiffness is related with clinical outcomes. Meshes with low stiffness can 
result in mesh failure due to inadequate mechanical support (20) and difficulty in 
handling during surgery due to excessive flexibility (21). Meshes with high stiffness lead 
to clinical complications, such as postoperative pain and discomfort (20).  
 Mesh stiffness can be measured using uniaxial tensile testing (22), biaxial tensile 
testing (23-26) or ball burst testing (22). Biaxial tensile testing was used in this 
dissertation using a biaxial tensile tester equipped with orthogonal 23N load cells and a 
high-resolution CCD imaging system for image-based strain measurement (BioTester, 
CellScale, Ontario, Canada), as described in Chapter 3 and Chapter 4. Mesh pore size 
deformation can be minimized in biaxial tensile testing (27), achieving higher measured 
mesh stiffness (25), compared to uniaxial tensile testing (20, 28, 29). Mesh anisotropy 
can be evaluated using biaxial tensile testing, compared to ball burst testing (17, 25). 
The stiffness of pristine PP meshes in MeshWatch ranges from 149.0 N/cm to 
300.4 N/cm in longitudinal direction (𝑆4) and from 79.0 N/cm to 245.4 N/cm in 
transverse direction (𝑆5) (Appendix B) (Table 1.3), compared to referenced PP mesh 
stiffness ranging from 75.7 N/cm (25) to 191.1 N/cm (24) in 𝑆4 and 37.5 N/cm (25) to 
177.8 N/cm (25) in 𝑆5. VentralexÔ was not included in Table 1.3 due to the limited mesh 
dimension available for testing. PP mesh stiffness is much lower than PP fiber stiffness, 
which is approximately 50,000 to 110, 000 N/cm based on estimates using the surgical 
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mesh thickness at 0.5 mm (22, 30) and the elastic modulus of PP fiber ranging from 10 to 
22 GPa (13). The difference is induced by the loop structures of warp-knitted mesh (31).   
Table 1. 1. Mesh structure information 
Brand Material Structures Mesh Class  
Porosity/Pore 
size Ref 
ComposixÔ 
E/X PP sewn to ePTFE film 
 
III 0.43 mm2 (22) 
ComposixÒ 
KugelÒ PP sewn to ePTFE film 
 
III 57% (32) 
ComposixÔ 
L/P PP sewn to ePTFE film 
 
III 64% (32) 
C -QURÒ PP with omega 3 fatty acid layer 
 
III 0.33 mm2 (22) 
PhysiomeshÔ 
PP/polyglecaprone-25 
(PG-25)/ 
polydioxanone (PDS) 
Old structure:
 
New structure:
 
III 
6.50 mm2 
 
 
 
63% 
 
 
(33) 
 
 
 
Measured 
as in 
Chapter 2 
Proleneâ Soft PP 
 
I 67% (34) 
Ultraproâ PP/PG-25 
 
I 67% (6) 
VentralexÔ PP sewn to ePTFE film 
 
III 57% 
Measured 
as in 
Chapter 2 
VentralightÔ PP/polyglycolic acid (PGA) 
 
III 43% (34) 
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Table 1. 2. Mesh thermal properties 
Brand 
Measured 
Crystallinity 
(%) 
Referenced 
Crystallinity 
(%) 
Ref Measured Tm (°C) 
Referenced 
Tm (°C) Ref 
ComposixÔ E/X 46.2 47.0 (14) 165.5 166 (35) 
ComposixÒ KugelÒ 41.9 - - 166.9 - - 
ComposixÔ L/P 48.1 - - 169.2 - - 
Proleneâ Soft 46.9 - - 168.4 170.2 (36) 
Ultraproâ 44.3 42.1 (14) 168.1 166 (14) 
VentralexÔ 45.0 - - 164.5 - - 
     
Table 1. 3. Mesh stiffness 
Brand Measured 𝑺𝒚 (N/cm) 
Referenced 𝑺𝒚 
(N/cm) Ref 
Measured 𝑺𝒙 
(N/cm) 
Referenced 𝑺𝒙 
(N/cm) Ref 
ComposixÔ E/X 118.7 ± 22.9 - - 79.0 ± 18.3 - - 
ComposixÒ 
KugelÒ 187.8 - - 165.9 - - 
ComposixÔ L/P 194.7 ± 15.1 - - 122.1 ± 19.1 - - 
C -QURÒ 178.7 ± 6.6 177.00 ± 4.94 (25) 180.9 ± 2.8 177.78 ± 14.04 (25) 
PhysiomeshÔ 
(new structure) 149.0 ± 10.2 - - 142.4 ± 16.9 - - 
PhysiomeshÔ 
(old structure) - 168.91 ± 26.91 (25) - 151.62 ± 26.57 (25) 
Proleneâ Soft 153.8 ± 4.8 - - 113.0 ± 9.5 - - 
Ultraproâ 152.7 ± 9.2 98.63 ± 6.13 171.2 ± 78.9 
(25) 
(24) 82.2 ± 5.3 
53.01 ± 5.41 
79.6 ± 11.4 
(25) 
(24) 
VentralightÔ 300.4 ± 37.1 123.57 ± 10.04 (25) 245.4 ± 22.9 50.82 ± 4.61 (25) 
 
Factors Affecting Mesh Properties in the MeshWatch Registry  
Comparing explanted mesh to pristine mesh is challenging due to the elapsed time 
between implantation and explantation. The in vivo duration averaged 2.8 ± 2.8 years 
(range: 0.3 to 13 years) for mesh explants included in this dissertation. Mesh implant 
products are ever-changing, and several factors affecting mesh properties are noted, 
which must be kept in mind for all explanted and pristine mesh comparisons in this 
dissertation.  
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Mesh Recalls 
Mesh recalls lead manufacturers to modify products, which contributes to changes 
in mesh properties, such as mesh structures, mesh chemistry and mesh mechanics. 
ComposixÒ KugelÒ was recalled in 2006 and PhysiomeshÔ Flexible Composite Mesh 
was recalled in 2016. ComposixÒ KugelÒ was not available in the market after 2006 and 
the mesh design of PhysiomeshÔ Flexible Composite Mesh was changed after the recall. 
All ComposixÒ KugelÒ used as pristine controls in this dissertation have been expired for 
at least 10 years. Oxidation may occur on the expired unused mesh due to the long-time 
exposure to air. All pristine PhysiomeshÔ meshes within shelf life and used as pristine 
controls in this dissertation were manufactured in the new mesh structure after the recall 
(Table 1.1) with different mechanical properties (Table 1.3), which was different from 
the old structures of most explanted PhysiomeshÔ retrieved from patients. All explanted 
PhysiomeshÔ meshes were implanted in patients no later than 2016, as described in 
Chapter 3, adding to the differences in material properties between explanted meshes and 
pristine controls.  
Absorbable Components in Class III Mesh 
The in vivo resorption of absorbable components changes mesh properties, such 
as mesh structure and mesh stiffness (21, 34, 37). The absorbance of PGA changes pore 
size of VentralightÔ (Figure 1.1). The absorbance of PDS/oxidized cellulose in Proceedâ 
results in same mesh structure and same chemistry as Proleneâ Soft (Figure 1.1), 
increasing the difficulty of identifying mesh types of explanted mesh retrieved from 
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patients (16). The in vivo resorption of absorbable components leads to notable reduction 
in mesh stiffness (21, 34, 37).  
    
Pristine VentralightÔ Explanted VentralightÔ  Pristine Proceedâ  Pristine Proleneâ Soft 
Figure 1. 1. Mesh before and after resorption of absorbable components.  
Different pore size between pristine VentralightÔ and explanted VentralightÔ; same 
mesh structure between Proceedâ and Proleneâ Soft. Scale bar: 1000µm. 
 
Manufactured Year 
 Even though a mesh type is assigned the same brand name and is considered the 
same mesh type, manufacturing in different years can result in different material 
properties, such as different polymer chemistry and mesh stiffness. As documented in 
detail in Chapter 3 and Chapter 4 of this dissertation, the measured crystallinity of unused 
ComposixÔ E/X manufactured in different years (expiration date on the packages: 2013 – 
2019) ranges from 43.1% to 52.4% (Figure 1.2). The measured biaxial tensile stiffness 
for pristine Ultraproâ (expiration date on package: 2019) is 152.7± 9.2 N/cm in 𝑆4 and 
82.2 ± 5.3 N/cm in 𝑆5 (Figure 1.3), compared to the measured stiffness for expired 
Ultraproâ (expiration date on package: 2015) of 130.6 ± 9.8 N/cm and 64.7 ± 10.7 N/cm. 
Those values differ from previous studies (Table 1.3) by Deeken et al. (25) and Cordero 
et al. (24) using similar testing methods.  
In this dissertation, all explanted meshes were originally implanted in patients 
between 2001 to 2016 but all pristine meshes were manufactured between 2015 to 2019, 
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possibly leading to different crystallinity and stiffness between pristine mesh implanted 
in patients before implantation and pristine controls for comparison. The pristine meshes 
used in this dissertation were manufactured in different years according to the study 
duration of each chapter: Chapter 2 was accomplished between 2015 to 2017; Chapter 3 
was accomplished between 2017 to 2019; Chapter 4 was accomplished in 2019; and 
Chapter 5 was accomplished between 2016 to 2018. 
 
Figure 1. 2. Measured crystallinity of ComposixÔ E/X manufactured from different 
years with testing methods documented in detail in Chapter 3 and Chapter 4.  
Meshes were identified using the expiration date on the packages. 
 
Figure 1. 3. Measured and referenced biaxial stiffness of Ultraproâ manufactured from 
different years with testing methods documented in detail in Chapter 3 and Chapter 4.  
Deeken_2014 and Cordero_2015: values from references (25) (24). Measured meshes 
were identified using the expiration date on the packages. 
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CHAPTER TWO 
 
PORE SIZE ANALYSIS OF EXPLANTED SURGICAL MESH USING 
PHOTOGRAMMETRIC METHOD 
 
 
Introduction 
Synthetic surgical mesh is a type of knitted textile polymer material implanted 
within the body to reinforce body tissues, such as the abdominal wall. Annual global use 
exceeds 20 million hernia repairs utilizing surgical mesh because of its efficacy in 
clinical outcomes (1). However, mesh gross contraction and other complications can be 
caused by tissue integration and by a foreign body response occurring around the mesh 
(2-5). In addition to the mesh material and mechanical properties, these factors also are 
influenced by structural characteristics of the mesh, such as pore size. Polypropylene (PP) 
meshes with small pores can induce a greater inflammatory response and fibrotic tissue 
adhesion, compared to meshes with large pores (6-8). Therefore, it is clinically relevant 
to discriminate among pore size in surgical mesh. 
Most surgical meshes are manufactured using warp-knitting techniques to provide 
the flexibility and structural stability from the interlacing filament loops (9, 10). These 
surgical meshes differ from woven fabrics and weft knitted fabrics, which are formed by 
crossing of weft yarns and warp yarns and loops in a horizontal direction using a single 
yarn system, respectively. In warp-knitted meshes, the loop structure patterns are 
normally repeatable because of the identical lapping movements of the mesh filaments 
through guide holes attached to the same guide bar, contributing to the characteristic 
“pore pattern” (11). Pore pattern includes different pore sizes distributed throughout the 
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mesh (Figure 2.1). Specifically, pore size in warp-knitted mesh is determined by the 
filament diameter, stitch density (number of stitches/cm), and loop structure, as well as 
post-treatment processes (12). Altering these parameters results in a varied mesh structure 
with a repeating pattern of different sized pores (Figure 2.1). Smaller diameter and stitch 
density can increase maximum pore size (12). Different loop structures result in different 
pore sizes regardless of the same lapping movements (Figure 2.1). 
Linking the analysis of pore size to textile structure is important for understanding 
the mechanical behavior of mesh, as pore size changes under tensile loads (13, 14). 
Applying uniaxial tension to a warp-knitted mesh will initially cause movement of the 
loop knots and straightening of the curved loop filaments along the uniaxial direction, 
followed by stretching of loop filaments and eventually filament failure (Figure 2.2) (12, 
15, 16). For these reasons, changes in pore size in implanted mesh are likely due to 
mechanical loading during surgical handling and contraction of abdominal wall muscles 
or other tissues adjacent to the mesh. Evaluation of pore size in different commercially 
available meshes has not included meshes explanted from patients (12, 17). Analysis of 
explanted mesh provides a unique opportunity to evaluate pore size after exposure to 
physiological conditions in humans.  
The overall purpose of this study was to evaluate changes in pore size after 
physiological loading by comparing explanted mesh and pristine mesh and relating it to 
the pore pattern. This was accomplished using a new automated digital photogrammetric 
method to measure pore size based on the pore pattern of two different types of 
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commercially available PP surgical meshes. It was hypothesized that pore sizes in 
explanted meshes and pristine meshes were similar. 
 
Figure 2. 1. Mesh knitting-lapping movements and pore patterns.  
(a-c): warp-knitted mesh with knitting-lapping movements (red line and green line). a&b: 
mesh with same knitting-lapping movements may have different pore sizes. (d-f): pores 
in mesh follow repeating patterns (pores with red outlines). Scale bar: 1000 µm. 
 
 
Figure 2. 2. Mechanical behavior of loops under uniaxial force.  
Along the uniaxial direction, loop knots start to move and the curved loop filaments are 
straightened, followed by stretching of loop filaments and eventually filament failure. 
Figure is adapted from reference (11). 
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Materials 
Two mesh types were selected from an IRB-approved registry of mesh explants: 
one standard weight small pore mesh and one light weight large pore mesh (Table 2.1) 
(18, 19). Seventeen small pore meshes and eight large pore meshes were acquired after an 
average implantation time of 28 ± 19 months and 23 ± 27 months, respectively (Table 
2.2). Meshes were retrieved from various locations on the abdominal wall (e.g. upper or 
lower quadrant and umbilical region). Reasons for mesh removal included hernia 
recurrence, infection, chronic inflammation, seroma, incarcerated hernia and bowel 
obstruction (Appendix A). Tissues remaining on the mesh were digested by immersing in 
8.25% hypochlorite solution at 37°C for at least 2 hours depending on the amount of 
tissue. Fat residues were removed with sonication in 5% detergent and 5% distilled water 
for 5 minutes for each mesh (20). Average reduction in pore size due to the tissue 
removal process was less than 3%. The dimension of mesh samples for pore size analysis 
was 2.54 cm × 2.54 cm. Pristine meshes of the same brands were used as control groups.  
Table 2. 1. Mesh information 
 Small pore mesh Large pore mesh 
Brand ComposixÒ KugelÒ  Proleneâ Soft 
Weight (g/m2) 95 45 
Classification (18,19) Standard, III Light, I 
Porosity 57% 66% 
Structure 
  
Material PP sewn to ePTFE film Lightweight PP 
Coda’s classification: ultra-light: < 35 g/m2; light: 35 ~ 70 g/m2; standard: 70 g/m2 ~ 140 
g/m2; heavy: ≥ 140 g/m2.  
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Table 2. 2. Patient demographics for explanted mesh  
Mesh Number (F/M) In vivo time (months) Patient age (years) BMI 
Small pore mesh 17 (7/10) 28 ± 19 62 ±13 31 ± 5.2 
Large pore mesh 8 (3/5) 23 ± 27 59 ±17 30 ± 3.3 
  
Photogrammetric Method  
The photogrammetric method included image capture, image processing and 
image analysis to classify pore pattern, to measure pore size and to evaluate changes in 
pore size after physiological loading. 
Image Capture 
Mesh pore size was measured using a modified digital photogrammetric method 
based on the work of Mühl et al. (17). Mesh samples (2.54 cm × 2.54 cm) were mounted 
onto a square mesh holder (2.5 cm length ´ 3.5 cm height) fabricated from clear acrylic 
(0.3175 cm thickness) to allow for optimal light transmission. Mesh samples were fixed 
onto the mesh holder under uniform tension (0.039 N) and illuminated with transmitted 
light using a stereo optical microscope (SMZ-168, Motic, Richmond, Canada). Calibrated 
digital images (1392 ´ 1040 pixels, 96 dpi, RGB, TIFF format) were acquired at 
magnifications of 6x (0.124 pixel/μm) for large pore mesh and 12x (0.243 pixel/µm) for 
small pore mesh using the attached digital camera (Infinity 2, Lumenera, Ottawa, 
Canada). The magnifications and light intensity were selected to provide adequate 
resolution of the mesh filaments while fully capturing the pore pattern of each mesh type. 
Using this procedure, the average variance in pore size due to image capture by different 
operators was controlled within 5% (21). 
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Image Processing 
Automated detection of pores was pursued to minimize human errors and avoid 
the time-consuming steps required for manual digitization. Image processing algorithms 
were programmed (Matlab R2016a, Mathworks, Natick, MA) to accomplish three steps: 
binary image conversion, noise removal and region selection (Figure 2.3). These steps 
were optimized for a single image of each mesh type and then applied to process the large 
quantity of acquired images. Final data output included pore sizes scaled for the image 
magnification using the calibrated pixel parameters.  
Binary image conversion was used to compensate for uneven illumination caused 
by the surface, structure and transparency of the polypropylene fibers. Wolf’s algorithm 
for binarization overcomes global threshold limitations by using local image thresholding 
in terms of contrast instead of actual gray values of the pixels (22-24). The original RGB 
color images (3-D arrays) were converted to grayscale images (1-D array) using standard 
transform coefficients (I = 0.2989 *R + 0.5870 * G + 0.1140 *B, with individual values 
from 0 to 255 for each pixel). A rectangular window was defined and shifted across the 
image, with the user optimizing the window size for edge detection of individual fibers 
defining the pore pattern. Thresholding was accomplished in the rectangular windows 
and an appropriate local threshold value (T) was calculated using Wolf’s algorithm: 
𝑇 = (1 − 𝑎)𝑚	 + 𝑎𝑀	 + 𝑎 C
D
	(	𝑚 −𝑀), R = max (s), 
where “a” was a gain parameter, “M” was the minimum value of gray level of the 
entire image, and “R” was set as the maximum standard deviation of all windows of the 
image (23). This produced binary images with pore areas assigned a value of “1” (white) 
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and fiber edges assigned a value of “0” (black). It was confirmed that the difference 
between the original and binarized image resulted in £ 5% deviation in fiber diameter. 
Noise removal, including random pixels within the pore and within the fiber, was 
recognized in the initial image by the user and then automatically filtered for subsequent 
images. The size of random pixels in the noise regions and the ratio between the major 
and minor axis of noise in fibers appearing in the shape of long thin sticks were set as 
filter parameters by the user. Such noise was originated from over-exposure, reflection 
and other contaminants during image acquisition. 
Region selection was visually confirmed by the user with appropriate pore 
inclusion or exclusion according to the pore pattern, and removal of incomplete pores 
near the image border that lacked a defined circumference of fibers. The user was able to 
manually add or delete pores as needed, depending on image quality. Final pore size was 
calculated as the number of pixels in white areas measured in the processed images and 
converted into square micrometers according to the calibration factor (length/pixel ratio) 
of the microscope-digital camera system. User inputs for image processing of a given 
mesh type were saved as a final configuration file and then applied to numerous images 
of the same type of mesh.  
Image Analysis 
The number of images per mesh type was determined using an over-sampling 
approach and evaluating deviations from true pore size due to measurement errors and 
variations in pore size within each mesh sample (25). This approach determined the 
minimum number of pores needed to represent the median true pore size within 5% based 
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on the pore pattern and pore size distribution. Multiple images of pristine mesh type (60 
images for large pore mesh, 50 images for small pore mesh) were analyzed, providing for 
measurement of over 1000 pores per type and calculation of the true pore size. Meshes 
were assumed to be uniform over all measured areas. The first step to determine the 
minimum number of pores needed to represent the pore size used  
𝑛 = 	
(FGH )
HIH
JH
 ,  
where n is the sample number of pores, Z is the critical value for a standard 
normal distribution at a = 0.05, s is the population variance, and E is the error arbitrarily 
set to be within 10% of the true pore size. The second step was to increase the calculated 
sample number (n) of pores gradually (e.g. n+1, n+2, etc.) until the average pore size 
measured using the sample number of pores was not significantly different compared to 
the true pore size. Pore size for explanted meshes was measured from the minimum 
number of pores and compared to the pristine meshes. Differences between the pore size 
of pristine and explanted meshes was analyzed by t-test and Wilcoxon Signed Rank Sum 
Test (a = 0.05). All statistical analyses were run in OriginLab 9.0 (Northampton, 
Massachusetts, USA). 
 
 
Figure 2. 3. Photogrammetric method. 
The captured image was process by step 1. binary image conversion, step 2. noise 
removal, step 3. region selection, step 4. measured pore size output. 
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Results 
Pore Size Distribution  
 There was a broad variation in pore sizes within the small pore and large pore 
meshes, with definitive bin groups easily visualized in histograms of the pristine meshes 
(Figure 2.4). There were two pore bin groups in the small pore mesh and four pore bin 
groups in the large pore mesh based on the pore pattern and pore size distribution (Table 
2.3). These bins were consistent with the pore pattern and in some cases, different pore 
shapes had similar pore sizes (Figure 2.4b). The pore pattern in the small pore mesh 
consisted of two pore shapes with two bin groups of different pore sizes, namely bin 1 (0-
0.4 mm2) and bin 2 (0.4-0.7 mm2) (Figure 2.4a). The pore pattern in the large pore mesh 
consisted of nine pore shapes with four bin groups of different pore sizes, namely bin 1 
(0-0.3 mm2), bin 2 (0.3-0.8 mm2), bin 3 (0.8-2.6 mm2), and bin 4 (2.6-4.0 mm2) (Figure 
2.4b).  
Based on the oversampling approach, the minimum number of pores needed to 
represent the true pore size varied with pore pattern. Small pore mesh required a 
minimum of 3 pores in both bin 1 and bin 2 for the measured pore size to be statistically 
similar to the true pore size (Wilcoxon test, p > 0.05). Large pore mesh required a 
minimum of 60, 11, 22, and 6 pores in bin 1, bin 2, bin 3 and bin 4, respectively for the 
measured pore size to be statistically similar to the true pore size (Wilcoxon test, p > 
0.05). These minimum numbers of pores were further used for data collection for 
explanted meshes.  
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Figure 2. 4. Histogram of pore size distribution in pristine meshes.  
a. Two bin groups in small pore mesh: bin 1 (0-0.4 mm2) included same pore shapes with 
blue outline; bin 2 (0.4-0.7 mm2) included same pore shapes with red outline. b. Four bin 
groups in large pore mesh: bin 1 (0-0.3 mm2) included pores with yellow outline; bin 2 
(0.3-0.8 mm2) included pores with green outline; bin 3 (0.8-2.6 mm2) included pores with 
blue outline; bin 4 (2.6-4.0 mm2) included same pore shapes with red outline. The pores 
in bin 1, bin 2 and bin 3 were in different pore shapes. Scale bar: 1000 µm. 
 
Pore Size Change after Implantation 
The changes of pore sizes depended on the pore shapes. The changes of pore sizes 
in bin 1 in both explanted meshes were not significantly different from the pristine 
controls (t-test, p > 0.05) (Table 2.4). However, the explanted meshes in both types had 
significantly smaller pore sizes in the large bins (bin 2 for small pore mesh, bin 2, 3 & 4 
for large pore mesh) compared to the pristine controls (t-test, p < 0.01) (Table 2.4). The 
pore sizes of bin 1 (0-0.4 mm2) in the individual explanted small pore mesh with 24-
month and 38-month implantation time increased, which contributed to the reduction of 
pore sizes in bin 2 (0.4-0.7 mm2) due to the flexible knitted structure (Figure 2.5a). This 
also resulted in the increased pore size of bin 1 (0-0.3 mm2) in large pore mesh with 13-
month implantation time (Figure 2.5b). Nearly all explanted meshes in both types (23 of 
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25) had significantly smaller pores in the largest bin groups (bin 2 for small pore mesh, 
bin 4 for large pore mesh) compared with pristine control meshes (Wilcoxon test, p < 
0.05) (Figure 2.5), including 16 out of 17 explanted small pore mesh had significantly 
smaller pores (Wilcoxon test, p < 0.05) in bin 2 compared to pristine mesh and 7 out of 8 
explanted large pore mesh had significantly smaller pores (Wilcoxon test, p < 0.05) in bin 
4 compared to pristine mesh. The difference between unchanged or increased pore sizes 
of explanted mesh and pristine mesh was much smaller than the difference between 
decreased pore sizes and pristine mesh, which indicated the overall reduction of pore 
size. The difference between pristine and pristine mesh treated by chemicals was smaller 
than the difference between pristine mesh and explanted mesh, which indicated the 
shrinkage of pore size occurred during implantation.   
Table 2. 3. The pore sizes within the pristine pore bins were normally distributed 
Mesh type 
Measurements of pores without bins Measurements of pores based on bins 
Mean ± SD 
(mm2) Median (mm
2) Bin # (range) (mm2) 
Mean ± SD 
(mm2) 
Median 
(mm2) 
Small pore 
mesh 0.35 ± 0.22 0.49 
1 (0.0-0.4) 0.08 ± 0.01 0.08 
2 (0.4-0.7) 0.53 ±0.04 0.53 
Large pore 
mesh 1.00 ± 0.99 0.54 
1 (0.0-0.3) 0.14 ± 0.05 0.13 
2 (0.3-0.8) 0.53 ± 0.09 0.51 
3 (0.8-2.6) 1.64 ± 0.38 1.63 
4 (2.6-4.0) 3.22 ± 0.29 3.26 
 
Table 2. 4. Pore size of explanted meshes and p-values compared with pristine meshes  
Mesh type Bin Explanted mean ± SD (mm2) 
Pristine mean ± SD 
(mm2) T-test 
Small pore mesh 
1 0.08 ± 0.01 0.08 ± 0.01 p = 0.49 
2 0.44 ±0.05 0.53 ±0.04 ** 
Large pore mesh 
1 0.13 ± 0.02 0.14 ± 0.05 p = 0.22 
2 0.39 ± 0.04 0.53 ± 0.09 ** 
3 1.48 ± 0.12 1.64 ± 0.38 ** 
4 2.85 ± 0.28 3.22 ± 0.29 ** 
*: p < 0.05, **: p < 0.01 
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Figure 2. 5. Comparison between pore size in explanted mesh and pristine mesh.  
Pore area as a function of implantation time for a) small pore mesh and b) large pore 
mesh. Meshes with same implantation time were distinguished by sex (M/F) of the 
patient (Appendix A). Explanted mesh had significantly smaller pore sizes compared to 
pristine mesh for bin 2 in small pore mesh and bin 2, 3, 4 for large pore mesh.  
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Discussion 
This study developed an automated digital photogrammetric method using image 
capture, image processing and image analysis to measure pore size within the context of 
different pore patterns for two types of PP surgical mesh. The measurement system used 
a simple light microscopy set-up and automated detection of pores, which helped to 
minimize human errors and provide for efficient pore detection. Different pore patterns 
and pore size distributions were characteristic for different mesh types (Figure 2.4). 
Applying this method to explanted mesh, same pore sizes in small bins and significantly 
smaller pore sizes in large bins were detected compared with pristine control meshes 
(Table 2.4).  
Identifying pore pattern before measuring pore size is crucial because knitting 
structures affect pore shape and the associated pore size. From the view of knitting 
technology, two-guide bar structures are used to form larger pore sizes and specific net 
shapes, such as diamonds and hexagons (12). However, these shapes are not always 
symmetrical, especially when knitting using a single-guide bar structure. The 
photogrammetric technique in the current study provides for direct measurement of pore 
size area without assuming a symmetrical pore shape. Other studies approximate pore 
size using an assumed shape (e.g. square or circle), which can produce errors in pore size 
area measurements (12, 17). For example, assuming a 1 mm pore size (26), such 
simplifications assuming a square or circle shape lead to a 0.215 mm2 difference in pore 
size. Identifying pore pattern and measuring pore size area based on the actual pore shape 
within the identified pore pattern avoids this error.  
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Recognizing pore pattern and measurement of pore size support in vivo 
assessments of mesh shrinkage. In vivo mesh shrinkage generally describes changes in 
overall mesh dimensions, leading to expansion or shrinkage in the overall mesh size and 
changes in pore size. The observed reduction in pore size of explanted mesh support 
other studies that have documented changes in mesh size and pore size. Harsløf et al. 
reported 20% shrinkage in overall mesh change in a small pore mesh having comparable 
15% shrinkage, which was estimated by pore pattern and change of pore size in the small 
pore mesh in the current study (27). Coda et al. reported the alternation of pore size of 
various types of PP mesh ranged from -40% (shrinkage) to +58.5% (expansion) having 
comparable alternation of pore sizes in the current study from -19% (shrinkage) to +23% 
(expansion) (28). 
Linking the analysis of pore size to textile structure is important for understanding 
the mechanical compatibility between mesh and host tissues. When a mesh is implanted 
in the abdominal wall, the anisotropic host tissues will induce various force, such as 
biaxial tension on the implanted mesh. Applying biaxial tension on a warp-knitted mesh 
will induce various changes in mesh pore size due to the anisotropic and nonlinear mesh 
mechanical properties (29). When the whole pore diameter is less than 1 mm, tissue 
integration may not occur (6). The mechanical mismatch between implanted mesh and 
host tissues can result in mesh failure or failure of tissue integration.  
Structural stability and chemical composition of mesh can influence the degree of 
mesh contraction, providing possible mechanisms for the changes in pore size observed 
in the current study. Injury models of load-bearing tissues (e.g. tendon and muscle) 
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suggest that the abdominal wall may be dependent on mechanical strains to signal wound 
repair (30) and induce proliferation and parallel arrangement of fibroblasts and collagen 
fibers (31), which contribute to the difficulty of mesh recovery to its original pore 
structure after tissue removal (20, 32). In cases of infection and chronic inflammation, 
reactive oxygen species (ROS) and myeloperoxidase (MPO) are present around the mesh, 
capable of oxidizing PP mesh and causing radical scission and changes in crystallinity 
(33-36). The increased brittleness and loss of flexibility may contribute to the changes in 
mesh pore size. 
Limitations of this study are common to studies of explanted biomaterials, namely 
the meshes were obtained at the time of revision surgery without controlling for age, 
implantation time of mesh, or comorbidities of patients. Another limitation is that the 
imaging method assumes a two-dimensional projection for pore size measurement. The 
change in the size and shape of the stitches in cross-section view in physiological 
conditions is still unknown and needs to be studied in the future.  
Conclusion 
An automated digital photogrammetric method using image capture, image 
processing and image analysis to measure pore size was developed. Applying this method 
to explanted mesh, pore sizes in small bins were unchanged and pore sizes in large bins 
were 17% smaller for small pore mesh and 16% smaller for large pore mesh, on average, 
compared to pristine meshes. Given that movement of surrounding loops formed by warp 
knitted mesh filaments during loading can alter pore size in warp knitted mesh, it would 
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be beneficial to study the movement of mesh filaments in microscale in vivo and explore 
its impact on mesh-tissue interactions.   
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CHAPTER THREE 
 
ANALYZING MATERIAL CHANGES CONSISTENT WITH DEGRADATION 
OF EXPLANTED SURGICAL MESH RELATED TO CLINICAL 
CHARACTERISTICS 
 
 
Introduction 
Surgical guidelines recommend hernia mesh implants as the general standard for 
inguinal hernia repair (1). In use since the 1960s, polypropylene (PP) biomaterials are 
common in commercially available hernia meshes due to their high tensile strength, good 
flexibility, and chemical resistance (2). Although in vivo biomechanical and biochemical 
mechanisms have the potential to degrade biomaterials (3-8); the extent of in vivo 
degradation of PP mesh implants is currently under debate (9-11). Some studies of 
explanted PP mesh implants cite changes in chemical markers (e.g. surface oxidation and 
crystallinity) and physical markers (e.g. surface cracking and reduced compliance) as 
evidence of in vivo degradation of the PP mesh (6, 12-15). Other studies of explanted PP 
mesh implants cite an absence of changes in chemical markers, most notably in PP 
formulated with antioxidant stabilizers, and attribute surface cracking to artifacts from 
formalin-fixed proteins adhered to the mesh surface (3, 10, 16). Ineffective cleaning of 
explanted PP mesh (10) and highly variable clinical conditions, such as the presence of 
acute infection or chronic inflammation, further complicate these seemingly contradictory 
results (16). 
There are several mechanisms that potentially contribute to PP mesh in vivo 
degradation. One proposed mechanism involves reactive oxygen species (ROS) and 
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myeloperoxidase (MPO) that are present in cases of infection and chronic inflammation 
in peritoneal fluid (5, 17, 18). These chemicals are capable of oxidizing PP mesh and 
causing radical scission, and possibly leading to changes in crystallinity (5, 12, 15, 16, 
19). Another proposed mechanism involves sustained and cyclic mechanical strains in the 
mesh that exist during the surgical procedure and healing process and with patient 
activities after implantation (20-22). Such strains are capable of increasing localized 
stress, initiating structural cracks in individual fibers, and causing polymer chain scission, 
which may contribute to PP degradation such as surface cracking, changes in 
crystallinity, and even mesh failure (7, 12, 20, 21). The degraded PP may increase the 
inflammatory response around the implanted mesh, potentially increasing the 
concentrations of ROS and MPO and leading to further PP degradation (12).    
Highly variable in vivo conditions expose a mesh to a mechanism that potentially 
contributes to PP mesh degradation and complicates the analysis of explanted PP mesh. 
Surgical placement of the mesh within the peritoneal cavity (intra-peritoneal location) 
results in mesh being in contact with peritoneal fluid. The peritoneal fluid actively 
exchanges leukocytes with blood (23) and contains increased ROS released from 
leukocytes or macrophages in cases of infection or chronic inflammation (17, 24), thus 
creating the chemical environment for PP degradation. Surgical injuries or infection are 
the triggers causing fibrosis or scar formation of the peritoneum, applying increased 
mechanical strain on implanted mesh for PP degradation (23). Medical comorbidities, 
such as obesity (25), diabetes (26-28) and tobacco use (26) can alter and delay wound 
healing. These medical comorbidities can lead to chronic inflammation and abnormal 
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tension applied on mesh, creating the chemical and mechanical environment for PP 
degradation.  
Mesh selection also potentially contributes to PP mesh degradation. Mesh with 
small pore sizes has a larger surface contact area with host tissues, inducing higher 
inflammatory infiltrate to the mesh surface by attracting inflammatory cells, such as 
macrophages (29-31). These inflammatory cells on the mesh surface release ROS, 
increasing the amounts of ROS around the mesh and creating the chemical environment 
for PP degradation. Mesh with small pore sizes also induces less tissue integration but 
higher fibrous encapsulation, leading to higher tissue contraction (22, 32-34). This 
contraction applies mechanical strains on the mesh, creating a mechanical environment 
for PP degradation. Mesh with highly deformable pore shape can behave similarly to 
mesh with small pores under the biaxial tension caused by abdominal wall distension, 
healing process or tissue contraction (29, 35).  
To date, few studies of explanted PP mesh have explored specific mechanisms 
that potentially contribute to PP mesh degradation. Evidence of degradation is 
confounded by contamination from chemical fixatives and adhered biological debris, 
highly variable in vivo conditions that are infrequently documented, and small sample 
sizes that are not suitable for meaningful statistical analysis. There is need for explant 
analysis of PP hernia mesh that centers on potential degradation mechanisms and 
investigates clinical characteristics that may trigger material changes consistent with PP 
degradation. The purposes of this study were: 1) to evaluate mesh surface oxidation, 
crystallinity, and mechanical properties of fresh frozen explanted PP meshes; and 2) to 
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investigate whether material changes consistent with PP degradation are related to 
infection, mesh placement location, and mesh pore size. The hypothesis were: 1) mesh 
explanted from patients with infection had more PP material changes than mesh 
explanted from non-infected patients; 2) mesh implanted in an intra-peritoneal location 
had more PP material changes than mesh implanted in an extra-peritoneal location; and 
3) mesh with small pore size had more PP material changes than mesh with large pore 
size.  
Materials 
Hernia meshes were collected by the surgeon co-authors (BTH, VA) through an 
established registry of explanted meshes (MeshWatch) using a protocol approved by the 
Clemson University Institutional Review Board (IRB2014-161). Meshes from 
consecutive patients undergoing revision hernia surgery were archived and stored fresh-
frozen at -80° C until analysis. To date, there are 164 explanted hernia meshes of various 
types in the registry along with documentation of basic patient demographics and clinical 
history abstracted from available records and details of mesh structure and type. The 
registry database was queried to identify all meshes meeting five characteristic inclusion 
criteria. 1) The meshes were explanted by the same surgical team at the same medical 
center. 2) The mesh material was PP. 3) The meshes were received before the start of this 
study (December 2017). 4) The mesh structure was in the pictorial “MeshWatch” atlas of 
known mesh types in the mesh registry (36). 5) The mesh structure was warp knitted. 
Sixty-three meshes of 10 known mesh structures (9 mesh types, including two different 
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mesh structures for same mesh type, as described in Chapter 1, Table 1.1) met those 
inclusion criteria (n = 63) and were selected for further analysis.   
The included meshes (n = 63) were explanted from 62 patients after a median 
implantation time of 24 (range: 5 to 156) months. There were 32 female patients (average 
age at removal: 58 ± 11 years old) and 30 male patients (average age at removal: 59 ± 10 
years old), including two meshes retrieved from one male patient (Table 3.1). Patient 
records included sex, age at removal, BMI, and mesh implantation time. The year of the 
mesh implanted (range: 2002 to 2016) into a patient was estimated using the year of the 
mesh removed (range: 2013 to 2017) and the implantation time. Medical records included 
history of infection, diabetes, recurrent hernia, smoking and previous hernia repair. 
Surgical records included mesh placement and reasons for mesh removal. The reasons for 
mesh removal included infection (n = 8), incarcerated hernia (n = 29, two patients with 
both infection and incarcerated hernia), bowel obstruction (n = 2), mesh not working (n = 
15), chronic pain (n = 3), other individual issues (n =8). Some patients did not have full 
records: 1) Eight patients did not have records of recurrent hernia. 2) Four patients did 
not have records of implantation time. 3) Two patients did not have records of infection, 
including one patient who did not have a recorded history of mesh placement anatomic 
location, implantation time, diabetes, previous hernia repair, and reasons for removal.  
Using the data of medical records, the included meshes were grouped into meshes 
from infected patients (n = 8) and meshes from non-infected patients (n = 53). Based on 
the comorbidities, the included meshes were grouped into meshes from patients with 
diabetes (n = 16) and without diabetes (n = 46), with previous hernia repair (n = 44) and 
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without previous hernia repair (n = 18), with recurrent hernia (n = 52) and without 
recurrent hernia (n = 3), and with a history of smoking (n = 4) and without a history of 
smoking (n = 59).  
According to surgical records, the included meshes were grouped into two 
anatomic locations based on mesh placement before retrieval: intra-peritoneal (Intra) 
location (n = 24) and extra-peritoneal (Extra) location (n = 38). The extra-peritoneal 
location included four anatomic locations: onlay (n = 11), inlay (n = 4), underlay (n = 
15), and sublay (n = 8) (37).  
According to mesh selection, the included meshes were classified into three 
groups based on modified Klinge’s classification: Class I (n = 22) were large pore meshes 
(textile porosity > 60%); Class II (n = 23) were small pore meshes (textile porosity < 
60%); and Class III (n = 18) were meshes with special features, such as barrier layer or 
surface coating (Table 3.2) (38). For the explanted meshes, the presence of an absorbable 
surface coating at the time of implantation could not be traced and therefore, only meshes 
with an e-PTFE layer were classified into Class III. All other meshes were classified into 
Class I or Class II based on the porosity. Overall, the mesh explants represented 10 mesh 
structures of 9 different commercially available mesh types.  
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Table 3. 1. Patient information (Class I) 
Mesh 
# 
Mesh 
Class 
Sex 
(F/M) 
Age at removal 
(yrs) BMI 
Implantation 
time (mons) Mesh location 
1 I F 49 29.3 48 onlay 
2 I M 68 33.6 11 onlay 
3 I M 60 45.3 132 onlay 
4 I F 68 28.6 9 onlay 
5 I F 37 37.6 53 onlay 
6 I M 68 28.6 33 onlay 
7 I F 60 45.0 24 inlay 
8 I F 58 30.9 7 inlay 
9 I F 48 39.1 8 underlay  
10 I M 48 19.9 37 underlay 
11 I M 58 28.0 16 underlay  
12 I M 51 33.7 18 underlay 
13 I M 51 33.7 18 underlay 
14 I M 73 28.3 19 sublay  
15 I F 51 40.2 5 intra-peritoneal 
16 I M 50 30.5 25 intra-peritoneal 
17 I F 32 34.0 54 intra-peritoneal 
18 I F 67 30.1 22 intra-peritoneal 
19 I F 78 40.7 96 intra-peritoneal 
20 I M 57 29.9 9 intra-peritoneal 
21 I F 56 32.9 48 intra-peritoneal 
22 I F 41 33.5 12 intra-peritoneal 
 
Mesh # Infection (Y/N) Removal reason/ Recurrent hernia (Y/N) 
Smoker/Diabetes/Previous hernia 
repair (Y/N) 
1 N incarcerated hernia/Y N/N/Y 
2 N seroma/Y N/N/Y 
3 Y infection/Y N/N/N 
4 N incarcerated hernia/Y N/N/Y 
5 N incarcerated hernia/Y N/Y/Y 
6 N incarcerated hernia/Y N/N/Y 
7 N mesh not working/Y N/Y/N 
8 N mesh not working/Y N/N/Y 
9 N mesh not working/Y Y/N/Y 
10 N chronic pain/Y Y/N/N 
11 N incarcerated hernia/Y N/N/N 
12 Y infection/Y N/N/N 
13 Y infection/Y N/N/N 
14 N incarcerated hernia/Y N/N/Y 
15 Y infection/Y N/N/Y 
16 N mesh not working/Y N/N/N 
17 N incarcerated hernia/Y N/N/Y 
18 N incarcerated hernia/Y N/N/Y 
19 Y infection/Y N/N/Y 
20 N incarcerated hernia/Y N/N/Y 
21 N incarcerated hernia/Y N/N/N 
22 N mesh not working/Y N/N/Y 
 
 39 
Table 3.1. Patient information (Class II) 
Mesh 
# 
Mesh 
Class 
Sex 
(F/M) 
Age at removal 
(yrs) BMI 
Implantation 
time (mons) Mesh location 
23 II M 74 30.1 24 onlay 
24 II F 41 35.3 24 inlay 
25 II M 63 44.3 8 underlay 
26 II M 54 26.9 36 underlay 
27 II M 70 29.2 12 underlay 
28 II M 54 33.1 15 underlay 
29 II F 34 38.1 30 underlay 
30 II M 60 32.3 14 underlay 
31 II F 58 45.9 48 underlay 
32 II F 64 41.6 18 underlay 
33 II M 75 28.8 9 sublay  
34 II M 75 28.8 18 sublay 
35 II M 71 47.3 48 sublay 
36 II F 52 40.3 13 sublay 
37 II F 48 42.2 25 intra-peritoneal 
38 II F 65 36.7 15 intra-peritoneal 
44 II M 57 26.5 5 intra-peritoneal 
45 II F 75 30.8 31 intra-peritoneal 
41 II F 65 26.7 50 intra-peritoneal 
42 II M 71 28.7 13 intra-peritoneal 
43 II F 54 31.0 7 intra-peritoneal 
44 II F 61 29.5 28 intra-peritoneal 
45 II M 50 28.7 NA NA 
     
Mesh # Infection (Y/N) 
Removal reason/ 
Recurrent hernia (Y/N) 
Smoker/Diabetes/Previous hernia repair 
(Y/N) 
23 N mesh not working/Y N/Y/Y 
24 Y incarcerated hernia/Y N/N/Y 
25 N incarcerated hernia/Y N/Y/N 
26 N incarcerated hernia/Y N/N/Y 
27 N incarcerated hernia/Y N/N/Y 
28 N incarcerated hernia/Y N/N/Y 
29 N incarcerated hernia/Y N/N/N 
30 N incarcerated hernia/Y N/N/Y 
31 N incarcerated hernia/Y N/N/Y 
32 N incarcerated hernia/Y N/N/Y 
33 N mesh not working/Y N/N/Y 
34 N incarcerated hernia/N N/N/N 
35 N incarcerated hernia/Y N/Y/Y 
36 N mesh not /Y working/NA N/Y/Y 
37 N mesh not working/Y Y/Y/Y 
38 N mesh not working/Y N/N/Y 
44 N mesh not working/Y N/N/N 
45 N mesh attachment/Y N/N/N 
41 N bowel obstruction/N N/N/N 
42 N diastasis/Y N/N/Y 
43 N fistula/Y N/N/Y 
44 Y incarcerated hernia/Y N/Y/Y 
45 NA NA/NA Y/NA/NA 
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Table 3.1. Patient information (Class III) 
Mesh 
# 
Mesh 
Class 
Sex 
(F/M) 
Age at removal 
(yrs) BMI 
Implantation 
time (mons) Mesh location 
46 III F 58 35.5 29 onlay 
47 III F 68 31.5 156 onlay 
48 III M 38 34.8 NA onlay 
49 III M 69 28.0 9 inlay 
50 III M 44 34.4 13 underlay  
51 III F 64 25.0 11 underlay 
52 III M 43 44.4 84 sublay  
53 III F 54 48.9 NA sublay 
54 III M 65 36.0 34 sublay  
55 III M 75 28.3 15 onlay 
56 III F 69 32.5 133 intra-peritoneal 
57 III F 68 32.8 NA intra-peritoneal 
58 III M 55 29.0 120 intra-peritoneal 
59 III M 64 28.5 28 intra-peritoneal 
60 III F 42 50.5 96 intra-peritoneal 
61 III F 65 34.3 41 intra-peritoneal 
62 III M 65 27.7 132 intra-peritoneal 
63 III F 58 29.5 84 intra-peritoneal 
 
Mesh # Infection (Y/N) Removal reason/ Recurrent hernia (Y/N) 
Smoker/Diabetes/Previous hernia 
repair (Y/N) 
46 N incarcerated hernia/Y N/Y/Y 
47 N incarcerated hernia/Y N/N/Y 
48 N mesh not working/NA N/N/Y 
49 N incarcerated hernia/NA N/Y/Y 
50 N chronic pain/N N/N/N 
51 N seroma/NA N/N/N 
52 N hard mesh/Y N/Y/Y 
53 N incarcerated hernia/Y N/N/Y 
54 N incarcerated hernia/Y N/N/Y 
55 Y Infection/NA N/Y/N 
56 N mesh not working/Y N/Y/Y 
57 N incarcerated hernia/Y N/Y/Y 
58 N incarcerated hernia/Y N/Y/Y 
59 N chronic pain/NA N/N/N 
60 N bowel obstruction/NA N/Y/Y 
61 N mesh not working/Y N/N/Y 
62 N mesh not working/Y N/N/Y 
63 NA adhesion/Y N/N/Y 
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Table 3. 2. Mesh structures 
Class I (n = 22) 
    
Class II (n = 23) 
  
  
Class III (n = 18) 
    
 
Methods 
Explanted Mesh Handling 
The explanted meshes were handled carefully. Selected explanted meshes were 
thawed to room temperature and carefully flattened (Figure 3.1). Four full thickness 
biopsies of 8 mm diameter (2 biopsies from peripheral location and 2 biopsies from 
middle location) were collected from each mesh for histological analysis. Two additional 
2 cm ´ 2 cm mesh samples were cut for chemical and mechanical characterization. All 
biopsies and mesh samples were rinsed with 0.02 M phosphate buffer solution to remove 
excessive blood. Histological biopsies were fixed in 10% formalin buffer for 24 hours, 
followed by tissue processing, embedding, sectioning, and staining (39). The histology 
study is ongoing and will not be reported in this chapter. The adhered tissues on the mesh 
samples were removed before chemical and mechanical characterization.  
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Figure 3. 1. Mesh handling and cleaning.  
 
Mesh Sample Cleaning 
The adhered tissues on the mesh samples were carefully removed using a 10-step 
modified cleaning protocol to avoid interference with subsequent analysis methods 
(Table 3.3) (10). Tissues were enzymatically removed by immersing in 1.5% NSPO034 
protease solution (Novozymes, Bagsværd, Denmark) and 1.5% Alcalase 2.5 L 
(Novozymes, Bagsværd, Denmark) in 0.02 M phosphate buffer (pH = 7) at 50°C for 24 
hours, followed by 0.5% detergent (Novozymes, Bagsværd, Denmark) bath at 80°C for 
30 minutes. The tissue residues on mesh samples were further removed using fresh 
enzymatic solution and then fresh detergent solution for 2 hours respectively at 50°C in 
ultrasonic bath. The enzyme and detergent residues were rinsed off by Millipore water in 
ultrasonic bath at 50°C for 2 hours. Mesh samples were disinfected by soaking in 70% 
ethanol for 1 minute and rinsed in Millipore water and vacuum dried at ambient 
Select
Explanted meshes meet the criteria (n = 63)
Histology (4 biopsies) 
FTIR, DSC, SEM 
characterization
Mechanical 
characterization
Step 1-2. Incubate
Protease solution 
24 hours
Step 3-4. Incubate
Detergent at 80°C 
30 minutes
Step 5-6. Sonicate
Protease solution + 
detergent at 50°C 
2 hours
Step 7. Sonicate
Millipore water at 50°C
2 hours
Biopsied explanted mesh sample
HE stain
Herovici stain
Masson’s Trichrome
Cleaned mesh Cleaned mesh 
Step 8-9. Disinfect & Rinse
70% ethanol, Millipore waterVacuum dry before 
characterization
Tissue removal
x
Explanted 
mesh
Mesh Watch (n = 164)
Explanted 
mesh
Explanted 
mesh
Explanted 
mesh
 43 
temperature for chemical and mechanical characterization. Based on surgical record and 
visual identification of mesh structures, commercially available pristine meshes were 
processed as cleaned controls.  
Table 3. 3. Mesh sample cleaning protocol 
Step 1 Step 2 Step 3 Step 4 Step 5 
Remove blood 
using PBS buffer 
Digest tissues 
using enzyme 
solution at 50 °C 
for 24 hours 
Check if the tissues 
are fully removed 
from the mesh, 
yes ®step 4  
no®step 2 
Rinse and leave in 
0.5% detergent at 
80°C for 30 mins 
Sonicate using 
fresh enzyme 
solution at 50 °C 
for 2 hours 
Step 6 Step 7 Step 8 Step 9 Step 10 
Sonicate using 
fresh detergent 
solution 50 °C 
for 2 hours 
Rinse and 
sonicate in 
Millipore water 
50 °C for 2 hours 
Disinfect in 70% 
ethanol for 1 minute 
Rinse using 
Millipore water 
Vacuum dry 
before 
characterization 
 
Cleaning Validation 
Validation of cleaned mesh samples included visual assessment under a stereo 
optical microscope (SMZ-168, Motic, Richmond, Canada) and chemical assessment with 
Fourier-transform infrared spectroscopy (FTIR) (IRSpirit FTIR Spectrometer, Shimadzu, 
Kyoto, Japan), similar to the validation method reported by Thames et al. (10). Mesh 
samples with remaining adhered tissues were not translucent and had 1600-1690 cm-1 
spectral peaks in FTIR, whereas clean mesh samples were translucent and the 1600-1690 
cm-1 spectral peaks were absent. Based on preliminary testing, mesh samples were 
cleaned using the cleaning protocol (Table 3.3) until little improvement was observed 
under the microscope (Figure 3.2) and the peak representing proteins in the region of 
1600-1690 cm-1 (Figure 3.3a, red curve) was not observed under FTIR (Figure 3.3a, blue 
curve). The peak in the region of 3300 cm-1 was not used as protein indicator because the 
range of 3100 – 3600 cm-1 also represented hydroxyl groups (10, 40).  
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a. mesh explant b. sample cleaned once 
c. sample cleaned 
twice 
d. sample cleaned 
three times 
e. pristine cleaned 
control 
 
Figure 3. 2. Cleaning validation.  
The mesh sample was cleaned using the cleaning protocol until little improvement (image 
c and image d) was observed under light microscope. Mesh sample in image b was not 
translucent, compared to image c and d. 
 
Change in Surface Chemistry 
PP mesh surface degradation was characterized by detection of surface chemical 
changes on the cleaned mesh samples compared to pristine cleaned controls. Surface 
chemistry was measured using FTIR (IRSpirit FTIR Spectrometer, Shimadzu, Kyoto, 
Japan). The mesh surface was scanned in the range of 500 to 4000 cm-1 with resolution of 
4 cm-1. Compared to pristine PP mesh (Figure 3.3b), the mesh samples without surface 
chemical changes (Figure 3.3a, blue curve) had similar FTIR peaks, but mesh samples 
with surface chemical changes (Figure 3.3a, green curve) had evidence of carbonyl 
groups (1740 cm-1) (12, 19) or hydroxyl groups (3100 – 3600 cm-1) (5, 19). The 
observation of carbonyl groups confirmed the oxidation of the PP chain. The observation 
of hydroxyl groups confirmed the cross-linking of the hydrogen bonds to the PP chain 
(40).  
Although some meshes had absorbable films before implantation, such as 
poliglecaprone (Figure 3.3c), the peaks (580 cm-1, 725 cm-1 and 1081 cm-1) representing 
poliglecaprone film was not observed in explanted mesh samples, confirmed by FTIR 
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(Figure 3.3d) (41). Explanted mesh sample #2 (Figure 3.3d, red curve) and #7 (Figure 
3.3d, blue curve) were the same type mesh with absorbable materials (Figure 3.3c) before 
implantation. Both mesh samples (Figure 3.3d) were notably different from the pristine 
mesh samples with the intact absorbable layer (Figure 3.3c) with reduction of peaks of 
580 cm-1, 725 cm-1 and 1081 cm-1. Both mesh samples (Figure 3.3d) had peaks similar as 
pristine PP mesh (Figure 3.3b), confirming the observation of carbonyl groups (~1740 
cm-1) consistent with oxidative change in the PP surface chemistry.  
 
 
Figure 3. 3. FTIR of pristine and cleaned mesh samples.  
(a) FTIR of #56 after 1 cycle of 10-step cleaning (red) and after 2 cycles of cleaning 
(blue), compared to cleaned #41 (green) (b) FTIR of pristine (black) and cleaned pristine 
PP mesh (grey). 
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Figure 3.3. FTIR of pristine and cleaned mesh samples. (c) FTIR of cleaned pristine mesh 
with absorbable layer (grey) (d) FTIR of cleaned mesh samples after absorbance of 
absorbable layer #7 (blue) and #2 (red) after implantation. 
 
Change in Crystallinity Characterization 
PP mesh bulk degradation was characterized as the percent change in crystallinity 
for the cleaned explanted mesh samples compared to pristine cleaned controls. The 
degree of crystallinity was measured using differential scanning colorimetry (DSC) 
(Q1000 DSC Instrument, TA Instruments, New Castle, DE). The mesh samples were 
heated from 25 °C to 200 °C with heat rate of 20°C/min. The degree of crystallinity (𝑋𝑐) 
of the mesh samples was calculated from the tested heat of fusion (𝐻N) to the heat of 
fusion of 100% crystalline polypropylene (𝐻N,OPP), which equals 209 J/g (40). 
Eq. 1: Xc = 	 QN
QN,OPP	(RSPT	U/W)
	× 100%  
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The change of crystallinity (𝑋Z,Z[\]W^_) was determined by comparing to pristine 
cleaned controls (𝑋Z,`abCcb]^). 
Eq. 2: 𝑋Z,Z[\]W^_ = 𝑋Z,^5`d\]c^_ - 𝑋Z,`abCcb]^ 
The percent change in crystallinity was normalized relative to the crystallinity of 
pristine cleaned controls. 
Eq. 3:	𝑋Z,Z[\]W^_% = 
ef,fgGhijk
ef,lmnopnhj	
	× 100% 
Change in Stiffness Characterization 
Indirect characterization of PP mesh bulk degradation was evaluated as a change 
in stiffness for the explanted mesh samples compared to pristine cleaned controls. Mesh 
stiffness was calculated from mechanical behavior measured using a biaxial tensile test 
(BioTester, CellScale, Ontario, Canada). The mesh samples were preconditioned by 
soaking in 1x PBS solution at 37°C for 15 minutes. The hydrated mesh samples were 
clamped on the biaxial tester equipped with orthogonal 23N load cells and a high-
resolution CCD imaging system for image-based strain measurement, leaving a 2cm × 
2cm region of interest. Each test sample was preconditioned by 10 cycles of cyclic 
stretching at a speed of 0.2 mm/s with displacement of 5% tensile strain in both 
directions, followed by a stretching at the same speed to peak tension (35). Due to the 
anisotropic behavior of some mesh samples, all tested samples were aligned according to 
the notable longitudinal (y direction) and transverse directions (x direction) (Appendix B) 
(35, 42). The mesh stiffness 𝑆5 (N/cm) and mesh stiffness 𝑆4 (N/cm) were calculated as 
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the slope of the linear region of the tension-strain curves. The percent change in stiffness 
(𝑆Z[\]W^_	%) was normalized relative to the stiffness of pristine mesh.  
Eq. 4: 𝑆Z[\]W^_	%	 = 	
qjrlsGhpjk	tjog	oGtlsjuqlmnopnhj	tjog	oGtlsj
qlmnopnhj	tjog	oGtlsj
× 100%  
Due to the limited dimensions of some explanted mesh samples, only 35 
explanted meshes underwent mechanical testing and generated stiffness measures.     
Statistical Analysis (43)  
The patient demographics, medical conditions, surgical location, and mesh 
classification were independent variables (Table 3.4). The measured results were 
dependent variables. For patient and medical variables, sex (M/F), diabetes (Y/N), 
pervious hernia repair (Y/N), recurrent hernia (Y/N), infection (Y/N), and smoking status 
(Y/N) were dichotomous independent variables. Implantation time (months), estimated 
year of implantation, age (years), BMI were independent continuous variables. Surgical 
and mesh variables namely mesh location (intra/extra-peritoneal) and mesh class (Class I, 
Class II, Class III) were categorical independent variables. The measured surface 
chemical changes (𝐶qwaN\Z^) (Y/N) were dichotomous dependent variables and the 
crystallinity changes (𝑋Z,Z[\]W^_%) and stiffness changes (𝑆Z[\]W^_	%) were continuous 
dependent variables. 
The statistical analyses were performed using JMPâ Pro 14 (SAS Institute Inc, 
Cary, NC, USA) with 95% confidence interval for all tests. In the univariate analysis, the 
dependence between dependent dichotomous variables and independent dichotomous or 
independent categorical variables were analyzed using Chi square or Fisher’s exact 
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depending on sample size, or Cochran Armitage trend if the categories were more than 
two. The relation between continuous variables and dichotomous variables were analyzed 
using T test or Wilcoxon rank depending on the distribution of variables. The relation 
between dependent continuous and independent categorical variables were tested using T 
test, Wilcoxon rank or One-way ANOVA with Tukey’s post hoc depending on the 
distribution of variables and the number of categories. The correlation between dependent 
continuous variables and independent continuous variables were tested using Pearson or 
Spearman correlation.  
Multivariable associations were analyzed using logistic regression models for 
𝐶qwaN\Z^ and standard least squares for 𝑋Z,Z[\]W^_% and 𝑆Z[\]W^_	%. All characteristics 
for multivariable associations were selected using a cut-off of p £ 0.20 from estimated 
model using Adaptive Lasso with AICc Validation of all possible combined predictors. 
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Table 3. 4. Variables and statistical analysis methods 
Independent variables Dependent variables Statistical analysis 
Patient variables Measured results 
sex (M: n = 31/ F: n = 32) 
𝐶qwaN\Z^ (Y/N) Chi square 
𝑋Z,Z[\]W^_% 
𝑆Z[\]W^_	% 
T test or Wilcoxon rank 
implantation time (months) (n = 59) 
age at removal (years) (n = 63) 
BMI (n = 63) 
𝐶qwaN\Z^ (Y/N) T test or Wilcoxon rank 
𝑋Z,Z[\]W^_% 
𝑆Z[\]W^_	% 
Pearson or Spearman 
Correlation 
Medical variables Measured results 
diabetes (Y: n = 16 /N: n = 46) 
previous hernia repair (Y: n = 44/ N: n = 18) 
infection (Y: n = 8/ N: n = 53) 
smoking (Y: n = 4/ N: n = 59) 
𝐶qwaN\Z^ (Y/N) Chi square or Fisher’s exact 
𝑋Z,Z[\]W^_% 
𝑆Z[\]W^_	% 
T test or Wilcoxon rank 
Surgical variables Measured results 
mesh location (intra: n = 24 /extra: n = 38) 
𝐶qwaN\Z^ (Y/N) Fisher’s exact 
𝑋Z,Z[\]W^_% 
𝑆Z[\]W^_	% 
T test or Wilcoxon rank 
Mesh variables Measured results 
mesh class (Class I: n = 22, Class II: n = 23, 
Class III: n = 18) 
𝐶qwaN\Z^ (Y/N) Cochran Armitage trend 
𝑋Z,Z[\]W^_% 
𝑆Z[\]W^_	% 
One Way ANOVA 
 
Results 
Forty-six of the 63 FTIR tested mesh samples (73%) exhibited evidence of 
surface chemical changes. Twenty-one of the 62 DSC tested mesh samples (34%) 
exhibited crystallinity above or below the pristine control range. Thirty-five of the 35 
mechanically tested mesh samples (100%) exhibited changed stiffness behavior 
compared to pristine control mesh. 
Change in Surface Chemistry 
Forty-six of the 63 tested mesh samples (73%) exhibited evidence of surface 
chemical changes, including 14 of 22 Class I mesh samples (63%), 18 of 23 Class II 
mesh samples (78%) and 14 of 18 Class III samples (78%). PP mesh surface chemical 
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changes were independent from mesh class (Cochran Armitage, univariate p > 0.05) and 
not related with patient, surgical, and medical factors (Chi square or Fisher’s exact, 
Wilcoxon rank or T test, univariate p > 0.05) (Appendix C).  
When sublay and intra-peritoneal locations were coded into same group as 
recoded mesh placement location, 𝐶qwaN\Z^ was dependent on recoded mesh placement 
location (Chi square, univariate p = 0.03) (Figure 3.4). Multivariate associations with 
𝐶qwaN\Z^ were evaluated for recoded mesh placement location (univariate, p = 0.03) and 
recurrent hernia (univariate, p = 0.20) based on the estimated model selection from all 
possible combined predictors. Recoded mesh placement location (multivariate, p = 0.08) 
or recurrent hernia (multivariate, p = 0.26) did not affect mesh surface degradation (Table 
3.5). 
 
Figure 3. 4. 𝐶qwaN\Z^ (Y/N) count distribution (n = 63) based on recoded mesh placement 
location (sublay and intra-peritoneal vs other locations).  
Each mesh was labeled according to mesh class. Eight mesh samples from infected 
patients were labeled as bold black. 
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Table 3. 5. Univariate results and multivariable associations for significant factors 
 Outcome Univariate Comparison Mean/Median p value 
Multivariate 
Associations p value 
𝐶qwaN\Z^ 
Recoded mesh 
placement  Dependent 0.03* 
Recoded mesh 
placement  
Recurrent 
hernia 
0.26 
Recurrent 
hernia Independent 0.20 0.08 
𝑋Z,Z[\]W^_% 
Mesh class 
Mean class I = (-2.5 ± 5.1) % 
Mean class II = (4.1 ± 6.0) % 
Mean class III = (1.8 ± 8.4) % 
0.004* 
 
Mesh class 
 
BMI 
Age at 
removal 
0.008* 
BMI ρ = -0.20 0.11 0.24 
Age at removal r = 0.27  0.03* 0.17 
𝑆5,Z[\]W^_% Infection 
Mean infected = (-66.7 ± 13.4) % 
Mean no = (-36.6 ± 21.6) % 
0.01*   
𝑆4,Z[\]W^_% Infection 
Mean infected = (-64.9 ± 16.1) % 
Mean no = (-28.1 ± 25.0) % 
0.01*   
*: p < 0.05 
 
Change in Crystallinity 
Twenty-one of the 62 DSC tested mesh samples (34%) exhibited crystallinity 
above or below the pristine control range (41.9% to 50.0%) (Figure 3.5a). When 
normalized relative to the crystallinity of pristine mesh, 8 of the 62 samples (13%) had 
𝑋Z,Z[\]W^_% outside 10% (Figure 3.5b), with an average decrease of 2.5% (SD: 5.1%) for 
Class I, increase of 4.1% (SD: 6.0%) for Class II, and increase of 1.8% (SD: 8.5%) for 
Class III mesh samples (Table 3.5). Mesh class was a factor affecting changed 
crystallinity with significantly decreased crystallinity in Class I mesh samples compared 
to Class II mesh samples (One-way ANOVA with post hoc, univariate p < 0.01) (Table 
3.5). Changed crystallinity was also correlated with age at removal (Pearson, univariate p 
= 0.03) but not correlated with other patient, surgical or medical factors (T test, Spearman 
or Pearson, univariate p > 0.05).  
Multivariate associations with 𝑋Z,Z[\]W^_% were evaluated for mesh class 
(univariate p = 0.004), BMI (univariate p = 0.11), and age at removal (univariate p = 
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0.03) based on the estimated model selection from all possible combined predictors. 
Mesh class was a factor significantly affecting 𝑋Z,Z[\]W^_% (multivariate, p = 0.008) with 
controlling for effects of BMI (multivariate, p = 0.24) and age at removal (multivariate, p 
= 0.17). The fit of the estimated model was at r2 of 0.23.  
 
 
Figure 3. 5. Results of measured crystallinity (%) and calculated 𝑋Z,Z[\]W^_%.  
(a) Measured crystallinity of all explanted mesh samples (n = 62) grouped in mesh class, 
compared to pristine controls (shaded area). (b) Normalized percent change in 
crystallinity x𝑋Z,Z[\]W^_%y grouped in mesh class, relative to pristine controls. 10% 
range: shaded area. 
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Change in Stiffness 
Thirty-five of the 35 mechanically tested mesh samples (100%) exhibited changed 
stiffness behavior compared to pristine control mesh. The measured stiffness of cleaned 
explanted mesh samples ranged from 16.3 N/cm to 145.0 N/cm in x direction and from 
13.7 N/cm to 266.7 N/cm in y direction, compared to the range of pristine controls 
ranging from 80.7 N/cm to 158.5 N/cm in x direction and 134.9 N/cm to 265.2 N/cm in y 
direction (Figure 3.6a). When normalized relative to the stiffness of pristine control 
mesh, 𝑆Z[\]W^_	% ranged from decreased 86.1% (-86.1%) to decreased 5.5% (-5.5%) in x 
direction and decreased 89.8% (-89.8%) to increased 4.9% (+4.9%) in y direction (Figure 
3.6b). PP mesh stiffness changes in x and y directions were significantly decreased 
compared to pristine controls (One sample t test, univariate p < 0.05).  
Mesh samples from infected patients had average 𝑆5,Z[\]W^_% and 𝑆4,Z[\]W^_% 
of -66.7% (SD: 13.4%) and -64.9% (SD: 16.1%), compared to mesh samples from 
patients without infection averaging 𝑆5,Z[\]W^_% and 𝑆4,Z[\]W^_% of -36.6% (SD: 
21.6%) and -28.1% (SD: 25.0%) (Figure 3.7). Infection was a factor significantly 
affecting 𝑆Z[\]W^_% in both x and y directions (T test, univariate p = 0.01) (Table 3.5). 
Changed stiffness was not related with mesh, patient, surgical and other medical factors 
(One-way ANOVA, T test, Pearson or Spearman, p > 0.05). The estimated model of all 
possible combined predictors for both 𝑆5,Z[\]W^_% and 𝑆4,Z[\]W^_% only selected 
infection for multivariate associations.  
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Figure 3. 6. Results of stiffness (N/cm) and calculated 𝑆Z[\]W^_	%.  
(a) Stiffness (𝑆5 and 𝑆4) of all explanted mesh samples (n = 35) grouped by mesh class, 
compared to pristine controls (shaded area). (b) Normalized percent change in stiffness 
(𝑆Z[\]W^_	%) grouped by mesh class, relative to pristine controls. 
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Figure 3. 7. 𝑆Z[\]W^_	% of mesh samples from infected patients (n = 4) compared to mesh 
samples from non-infected patients (n = 30) in both x and y directions.  
Infection was a factor significantly affecting 𝑆Z[\]W^_	% (T test, univariate p = 0.01). 
 
Relation between Surface and Bulk Degradation 
Only 35 explanted mesh samples had data from all three characterization methods 
(surface chemical change, crystallinity and stiffness). Surface degradation was 
characterized by detection of surface chemical changes. Bulk degradation was 
characterized by changes in crystallinity and stiffness. Mesh surface chemical change was 
not a factor affecting changes of crystallinity or stiffness (T test, p > 0.05). Twenty-four 
of the 35 mesh samples (69%) with surface degradation had median 𝑋Z,Z[\]W^_% of 
+4.6%, compared to +3.1% of the 11 mesh samples without surface degradation. Mesh 
samples with surface degradation had average 𝑆5,Z[\]W^_% and 𝑆4,Z[\]W^_% of -43.2% 
(SD: 22.5%) and -36.2% (SD: 24.6%), compared to -35.3% (SD: 23.5%) and -24.7% 
(SD: 29.6%) of mesh samples without surface degradation. The changed crystallinity was 
not correlated with the changed stiffness (Pearson, p > 0.05). 
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Discussion 
This study explored mechanisms potentially contributing to PP mesh degradation 
using 63 explanted PP mesh samples with documentation of basic patient demographics, 
clinical history and details of mesh structures. The mechanisms were explored using 
evaluation of material changes after mesh samples were sufficiently cleaned, and analysis 
of multivariate associations between the material changes and clinical characteristics 
(Table 3.4). The material changes were characterized using surface chemistry changes, 
crystallinity changes, and stiffness changes consistent with chemical and physical 
markers cited as evidence of in vivo PP degradation in previous studies (6, 12-15). The 
findings in this study supported the proposed hypotheses that 1) infection was a factor 
affecting stiffness changes; 2) mesh with small pore size (mesh class) was a factor 
affecting crystallinity changes normalized to pristine controls. However, the study failed 
to support the hypotheses that 1) infection was a factor affecting surface chemistry 
changes and crystallinity changes; 2) mesh class was a factor affecting surface chemistry 
changes and stiffness changes; 3) mesh placement location was a factor affecting PP 
material changes.  
Multivariable associations used an estimated model to evaluate the significant 
impact of certain independent predictors on PP mesh material changes when combining 
all possible predictors (43). This study confirmed the significant impact of mesh class for 
changes in crystallinity (𝑋Z,Z[\]W^_%) when combining all possible predictors (Table 
3.5), consistent with other in vitro and in vivo studies (5, 44, 45). Mesh class significantly 
affected 𝑋Z,Z[\]W^_% in both univariate (One-way ANOVA with post hoc, univariate p = 
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0.004) and multivariate analysis (multivariate, p = 0.008), indicating crystallinity stability 
was determined by mesh class even with consideration of all possible predictors. This 
study used 𝑋Z,Z[\]W^_% instead of 𝑋𝑐 due to the different measured crystallinity of 
pristine meshes ranging from 41.9% to 50% (Figure 3.5), determined by manufacturers 
(5, 44). As to surface oxidation (𝐶qwaN\Z^), although there was a trend for PP mesh 
surface oxidation when mesh implanted in sublay and intra-peritoneal location (Chi 
square, univariate p = 0.03) (Figure 3.4), 𝐶qwaN\Z^ was independent on mesh implantation 
location in estimated model (multivariate, p = 0.08) (Table 3.5), indicating 𝐶qwaN\Z^ was 
not associated with any specific predictor when considering all possible predictors. As to 
changes in mesh stiffness (𝑆Z[\]W^_	%), although infection was a significant factor for 
𝑆5,Z[\]W^_% and 𝑆4,Z[\]W^_% (T test, univariate p = 0.01), it was unable to be analyzed 
in multivariate associations (Table 3.5), possibly due to the small sample size of only 4 
mesh samples from infected patients, compared to 31 mesh samples from non-infected 
patients.  
Evaluating explanted PP mesh material changes and their associations with 
clinical characteristics is important to predict the risk factors on PP mesh degradation. In 
this study, there were 46 of 63 explanted mesh samples (73%) with evidence of PP mesh 
surface chemistry changes (Figure 3.4), but only 8 of 62 explanted mesh samples (13%) 
had normalized crystallinity changes greater than 10%, compared to pristine controls 
(Figure 3.5b). Regardless of the material changes noted, none of the explanted mesh had 
evidence of gross mesh rupture while in clinical use. Due to the small number of 
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explanted mesh with evidence of material changes, it was not possible to discern whether 
the material changes had any impact on the clinical factors. 
This study only included PP surgical mesh used for hernia repair in the abdominal 
wall and the results should not be generalized to represent material changes for PP 
surgical meshes implanted in the pelvic floor. Evidence of polymer oxidation has 
occurred in other implanted polymeric biomaterials and is linked to exposure to 
mechanical stress or an oxidizing environment (46). Different from meshes implanted in 
the abdomen, pelvic floor surgical meshes are exposed to higher tension and have 
relatively greater risk of exposure to bacteria from the outside environment (21), resulting 
in higher mechanical strains and accumulation of ROS due to bacterial adherence. The 
estimated static loadings on implanted pelvic mesh were 10.5 – 15.5 N/cm, compared to 
the loadings of 7.5 N/cm for implanted hernia mesh (21). Pelvic surgical mesh 
degradation tends to occur, due to the polymer chain scission induced by mechanical 
strains or the infusion of ROS, compared to hernia mesh. 
Sufficient mesh cleaning is critical to avoid false observation of mesh surface 
oxidation associated with ineffective cleaning (10). The current study used a 10-step 
modified cleaning protocol (Table 3.3) and repeated cleaning cycles (Figure 3.2) to avoid 
interference with subsequent analysis methods. The use of enzymatic solutions instead of 
sodium chloride to removal tissues reduced the risk of PP oxidation due to sodium 
chloride (5, 47). The repeated use of enzymatic solutions assisted removing adhered 
proteins (10), caused by protein adsorption on the PP mesh surface after implantation 
(48). The use of fresh frozen explanted PP mesh instead of formalin-fixed explanted PP 
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mesh eliminated the formalin-fixed proteins strongly adhered to the mesh surface due to 
the chemical process of fixative crosslinking (3, 10, 16). Formalin-fixed proteins can 
have a morphology similar to PP surface cracking, which is difficult to distinguish from 
PP degradation under scanning electron microscopy (SEM) (10). The current study used 
FTIR to precisely distinguish adhered proteins and PP surface oxidation (Figure 3.3a), 
avoiding false observation of mesh surface cracking with SEM (9-11).  
Several limitations are noted. 1) Due to the nature of implant retrieval analysis 
after revision surgery (47), patient selection to control the clinical and surgical factors 
was not possible and it was unknown if these findings can be generalized to a broader 
population. 2) Due to the relative short implantation time (median 24 months), material 
changes expected for longer in vivo durations should not be extrapolated from the 
reported data. 3) It was difficult to generalize the relationship between infection and 
material changes due to the small number of infection cases. 4) There was limited 
documentation of mesh selection at index surgery and it was unknown whether the PP 
mesh had absorbable components or fibers containing antioxidants. Antioxidants can 
alter the surface chemistry changes caused by infection or chemicals in peritoneal fluid, 
compared to PP monofilaments without antioxidants (3, 10). In vivo resorption of 
absorbable components in PP mesh can reduce mesh stiffness (Figure 3.6) (49) compared 
to mesh without absorbable component (3, 5, 45), interfering with the observation of 
monofilament PP mesh stiffness changes in the current study. Such in vivo resorption also 
increased the difficulty of identifying mesh types due to the same mesh structure used for 
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mesh with and without absorbable component, such as Proceedâ and Proleneâ Soft, as 
compared in Chapter 1.  
There is a need for direct measurement of ROS in vivo to explore the proposed PP 
mesh degradation mechanism involving ROS accumulation, which are capable of PP 
radical scission (3, 5). In cases of infection, the immune response triggers ROS release to 
attack bacteria by reacting with organic molecules (17, 50-52), but ROS also exist in the 
process of wound healing to induce vascular endothelial growth factor expression (53) 
and the formation of peritoneal tissue adhesion (54). In the current study, 88% of mesh 
samples from infected cases and 70% of mesh sample from non-infected patients had 
surface oxidation (Figure 3.4), which supports the presence of ROS in both patient 
subsets, according to the results from other in vitro studies (5, 19). The direct 
measurement of ROS (17) assist more precise categorization of the current in vivo 
dataset.   
Similarly, there is a need for estimating in vivo mechanical strains on mesh to 
explore the proposed PP mesh degradation mechanism involving mechanical strains in 
the mesh, which are capable of increasing localized stress and causing polymer chain 
scission (7, 12, 20, 21). Mechanical strains in mesh can be influenced by fibrous 
capsulation or scar formation (21), excess abdominal adipose tissues (55), and altered 
wound healing process due to diabetes or smoking (55). Mechanical strains induced by 
the same applied tension magnitude can also vary due to mesh knitting structures (35), as 
confirmed by the different stiffness ranges for pristine control mesh of different mesh 
classes (Figure 3.6a). Although the current study analyzed the associations between 
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measured material changes and comorbidities (Table 3.5), such as BMI, diabetes, 
smoking status, the findings could not reflect the impact of quantified mechanical strains 
on PP mesh degradation. The direct measurement of mechanical strains (56) could assist 
analyzing the statistical correlation between mesh degradation and material changes. 
Conclusion 
 High variable in vivo conditions expose mesh to mechanisms that alter clinical 
outcomes and potentially contribute to mesh degradation. These PP mesh explants after 
0.5 to 13 years in vivo had measurable changes in surface chemistry, crystallinity and 
mechanical properties, with significant trends associated with factors of mesh placement, 
mesh class, and infection. Using multivariate statistical approach to control for clinical 
characteristics, infection was a significant factor affecting mesh stiffness changes and 
mesh class was a significant factor affecting PP crystallinity changes. However, given the 
small number of infection cases presumed to represent ROS accumulation, direct 
measures of ROS concentrations in the peritoneal fluid before retrieval surgery are 
recommended to generate a direct relationship between ROS concentrations and mesh 
material changes. This relationship would provide an estimate of the severity of 
inflammatory response and potential mesh material changes during in vivo exposure in 
patients. Given that mesh structures and mesh materials are commonly modified by 
manufacturers or removed entirely from the market, it is recommended that material 
properties for pristine meshes implanted in patients should be regularly measured and 
reported using standard methods. 
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CHAPTER FOUR 
 
UNDERSTANDING MECHANISMS OF POLYPROPYLENE HERNIA MESH 
DEGRADATION USING EXPERIMENTAL SIMULATIONS 
 
 
Introduction 
Polypropylene (PP) biomaterials are widely implanted as hernia mesh due to their 
chemical stability, high tensile strength and mechanical flexibility. However, it is debated 
whether PP mesh degrades in vivo (1-4), which identifies a critical need to understand 
possible mechanisms of PP mesh in vivo degradation. Studies suggest that mechanisms of 
PP mesh in vivo degradation may be related to exposure to reactive oxygen species 
(ROS) and mechanical strains (1, 4, 5). 
One proposed mechanism involves highly oxidative chemicals (ROS and 
myeloperoxidase) that are present in cases of infection and chronic inflammation in 
tissues adjacent to biomaterials (6) and in peritoneal fluid (5, 7, 8). These chemicals are 
capable of oxidizing PP, as a result of chain branching or chain scission of the PP, 
decreasing crystallinity and leading to more surface cracking. Another proposed 
mechanism involves the constant and cyclic mechanical strains that exist during the 
surgical procedure and healing process and with patient activities after mesh implantation 
(1, 9, 10). Mechanical strains in vivo caused by abdominal pressure and tissue integration 
can lead to expansion or shrinkage in the overall mesh size (11-14), changes in pore size 
(15), and adverse effects due to fibrotic tissue adhesion (16, 17). The applied mechanical 
strains can initiate cracks (18), resulting in surface cracking, brittleness, and an overall 
loss of flexibility (4, 19-22), as evidence of PP degradation.  
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It is unlikely that each mechanism alone will result in severe degradation (1) in a 
biological environment filled with fluids containing various chemicals (18). PP mesh 
degradation may be caused by the synergistic effect of ROS and mechanical strains. 
When exposing mesh to both ROS and mechanical strain, ROS may penetrate into the PP 
fiber through the free volumes or surface cracking caused by mechanical strains (18), 
increasing the potential for chain scission and cross-linking by chemical reaction. When 
considered in the extreme, the synergistic effect of ROS and mechanical strain could 
eventually lead to PP fiber rupture. However, the concentration of ROS is highly variable 
in the physiological environment (5) and its impact on PP mesh implants is poorly 
defined. 
There is a critical need to understand possible mechanisms that potentially 
degrade PP mesh in vivo. The purpose of this study was to define a physiological 
continuum of ROS concentration associated with chronic inflammation/infection and 
estimate the synergistic impact of varied ROS concentration and mechanical strains on 
PP mesh degradation using in vitro simulation. This study hypothesizes that: 1) higher 
ROS concentrations would result in greater PP mesh degradation, as evidenced by 
changes in surface appearance, oxidation, crystallinity, and stiffness; and 2) the 
synergistic effect of ROS and mechanical strains would lead to greater PP degradation 
than either mechanism alone. 
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Materials 
Meshes   
Unopened packages of unexpired large pore PP mesh (LP) (ProleneÒ Soft) (2, 23), 
unexpired composite small pore PP mesh (SP) (5, 23, 24) and expired composite small 
pore PP mesh (ESP) (ComposixÔ E/X) (Table 4.1) were acquired. The ePTFE films of 
SP and ESP were removed, leaving PP meshes for experimental simulation. Meshes were 
cut into 4 cm × 4 cm samples for in vitro studies of soaking in simulated solutions 
without applied mechanical strains, or 10 cm × 10 cm samples for in vitro studies of 
soaking in simulated solutions with applied mechanical strains. Meshes before soaking in 
any chemicals were used as pristine controls (PC).  
Table 4. 1. Mesh information before soaking 
Mesh Material Structures Mesh Class Porosity PP crystallinity 
LP PP 
 
I 67% 48.3% 
SP PP sewn to ePTFE film 
 
III 46% 47.6% 
ESP PP sewn to ePTFE film 
 
III 46% 49.4% 
 
Simulated Chemical Solutions  
The ROS solutions were simulated using 35% hydrogen peroxide (H2O2) 
(ThermoFisher Scientific, Ward Hill, MA) and cobalt chloride (CoCl2) (Sigma-Aldrich, 
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St. Louis, MO) (25). The control solutions were simulated using phosphate buffer saline 
(PBS) (ThermoFisher Scientific, Ward Hill, MA). Three different ROS concentrations 
were simulated: high ROS concentration (HROS), low ROS concentration (LROS), and 
without ROS (PBS). ROS concentrations in previous studies used to oxidize PP meshes 
were simulated using 20wt% H2O2 (6.29 M H2O2) (26-28) or 1.63M H2O2 (5). 
Considering 1.63M H2O2 as 1x ROS, 4x ROS was 6.52M H2O2, similar to 20wt% H2O2. 
Based on that assumption, the HROS solution was simulated using 6.52M H2O2 catalyzed 
with 0.05 M CoCl2 (6.52M H2O2/ 0.05M CoCl2) and the LROS solution was simulated 
using 1.63M H2O2 catalyzed with 0.05M CoCl2 (1.63M H2O2/ 0.05M CoCl2) (25). The 
PBS solution was simulated using 0.01 M PBS at pH 7.4.  
Simulated Mechanical Strains 
The mechanical strains (MS) on mesh were simulated using abdominal wall 
simulators (Figure 4.1) (29). A 10 cm × 10 cm mesh sample was placed and secured 
between two plates above an open circle area of 6.3 cm diameter (Figure 4.1). The open 
circle was used for mesh movement when air was purged into the system. The open circle 
was sealed by placing and securing two layers of thin latex resistance bands (Stamina 
Products, Springfield, MO) at 10 cm (length) × 10 cm (width) × 0.045 cm (thickness) 
below the inserted mesh sample. When air was purged into the system, mesh movement 
was achieved due to the movement of the resistance bands with modulus of 2.47 ± 0.09 
MPa (29, 30). The applied mechanical strain on each inserted mesh sample was 
monitored using the pressure gauge (Figure 4.1). The purged air pressure was maintained 
at 1.6 ± 0.2 psi, resulting in mechanical strains at approximately 5% based on the arc 
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length of the pressurized resistance bands (66 mm) relative to the original length when 
unpressurized (63 mm). Silicon grease (Dow CorningÒ, Midland, MI) was carefully 
applied to seal the gaps between each simulator component to avoid leaking without 
contaminating the inserted mesh samples. 
 
Figure 4. 1. Abdominal wall simulator with constantly purging air into the system (29). 
 
Experimental Design  
 
Figure 4. 2. Experimental design overview. 
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Different ROS Concentrations on PP Mesh Degradation  
Four samples of LP and SP were soaked in three different solutions: HROS, 
LROS and PBS (Figure 4.2). Mesh samples were wrapped inside glass wool 
(ThermoFisher Scientific, Ward Hill, MA) and then the glass wool was added to the 
solution to enhance interactions between the solution and the meshes (Figure 4.3) (25). 
The solutions were kept at 37 °C for 42 days and replaced every 3 to 4 days to maintain 
H2O2 concentrations, and the glass wool was changed every month to maintain the 
enhancement of interaction. Mesh samples (n = 4 meshes of each type per condition) 
were rinsed and vacuum dried for material characterization: HROS/21day, HROS/42day, 
LROS/42day and PBS/42day (Figure 4.2).   
 
Figure 4. 3. Mesh sample set-up in simulated solutions. 
 
Synergistic Effect of ROS and Mechanical Strains on PP Mesh Degradation  
Mesh samples in LROS/MS and PBS/MS were inserted in the abdominal wall 
simulators (Figure 4.1) in the same orientation. Each simulator was suspended over a 
glass petri dish containing simulated solution to soak the exposed 6.3 cm diameter mesh 
sample in the simulated solution (Figure 4.4). Glass wool was added above and below 
each mesh to enhance interactions between the solution and the mesh (Figure 4.3). The 
simulators with inserted mesh samples and simulated solutions were kept at 50 °C. The 
Glass Wool
Glass Wool
Mesh
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solutions, latex resistance bands and the glass wool next to the latex resistance bands 
were replaced every 3 to 4 days to maintain elasticity of the latex resistance bands with at 
least 75% strength in that timeframe. The high temperature facilitated the PP degradation 
with surface oxidation observed at Day 16. All mesh samples (LROS/16 day, PBS/16day, 
LROS/MS and PBS/MS) were rinsed and vacuum dried for material characterization at 
Day 16. 
 
Figure 4. 4. Mesh sample set-up with applied mechanical strains. 
 
Material Characterization 
Fourier Transform Infrared Spectroscopy (FTIR) 
Surface chemical changes (𝐶CwaN\Z^) for LP, SP, ESP mesh samples in their four 
simulated conditions (Figure 4.2) were characterized and compared to PC mesh samples 
using FTIR scans from 500 to 4000 cm-1 with a resolution of 4 cm-1 (Thermo-Nicolet 
Magna 550, ThermoFisher Scientific, Ward Hill, MA). Two measures were collected 
using one mesh sample for each simulated condition. Surface oxidation (𝐶CwaN\Z^ (Y)) 
was confirmed by the presence of peaks at 1740 cm-1 corresponding to the carbonyl 
groups (C=O) (19) or 3100 – 3600 cm-1 corresponding to hydroxyl groups (-OH) (31). 
Peaks for carbonyl groups confirmed oxidation of the PP chain and peaks for hydroxyl 
groups confirmed cross-linking of hydrogen bonds to the PP chain (5).   
6.3 cm diameter 
mesh sample 
Abdominal wall simulator 
Petri dish containing  
the simulated 
solution 
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Scanning electron microscopy (SEM)  
Surface defects (𝐷CwaN\Z^) on the fibers for LP, SP, ESP mesh samples in their 
four simulated conditions (Figure 4.2) were characterized and compared to PC mesh 
samples using SEM (Hitachi S3400, Hitachi, Tokyo, Japan). Three different images were 
captured using one mesh sample for each condition. Mesh samples were sputter coated 
with platinum and imaged at an accelerating voltage of 20 kV and magnifications up to 
1000x (5). Evidence of surface changes compared to PC mesh samples confirmed the 
presence of surface defects (𝐷CwaN\Z^ (Y)).  
Differential Scanning Calorimetry (DSC)  
Changes in crystallinity for LP, SP, ESP mesh samples in their four simulated 
conditions (Figure 4.2) were characterized and compared to PC mesh samples using DSC 
(Q1000, TA Instruments, New Castle, DE) from room temperature up to 200 °C with a 
heat rate of 20 °C/min. Approximately 3 grams of one mesh sample from each condition 
were characterized. The degree of crystallinity (𝑋𝑐) was calculated from the ratio of the 
measured heat of fusion (𝐻𝑓, 100) to the heat of fusion of 100% crystalline PP, which 
equals 209 J/g: 𝑋𝑐	 = 	 QN
QN,OPP	(RSPT	/-)	
	× 100%. The change of crystallinity was 
compared to PC mesh samples.  
Mechanical Testing 
Changes in stiffness for LP, SP, ESP mesh samples in their four simulated 
conditions (Figure 4.2) were characterized and compared to PC mesh samples using a 
biaxial test rig (BioTester, CellScale, Ontario, Canada), equipped with 23N load cells and 
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a high-resolution CCD imaging system for image-based strain measurement. Three mesh 
samples were tested for each condition except LROS/MS and PBS/MS. Due to the 
limited mesh sample size (6.3cm diameter circle) with mechanical strains, only one tested 
sample was available for mechanical testing. Two ESP mesh samples for LROS/MS and 
one ESP mesh sample for PBS/MS were tested. Each tested sample was cut to 3 cm ´ 3 
cm, mounted to produce a 2 cm ´ 2 cm region of interest, and stretched at a speed of 0.2 
mm/s in both directions to 10% strain to protect the load cell (32). Due to the anisotropic 
behavior of some mesh samples, all tested samples were aligned in the same orientations 
according to the notable longitudinal and transverse directions (Appendix B) (32, 33) and 
verified by images captured by Cellscale. The mesh biaxial stiffness 𝑆5 (N/cm) and 𝑆4 
(N/cm) was calculated as the slope of the linear region of the tension-strain curves. The 
change of stiffness in each direction was compared to PC mesh samples.  
Statistical Analysis 
The statistical analyses were performed using JMPâ Pro 14 (SAS Institute Inc, 
Cary, NC, USA) with 95% confidence interval for all tests. The simulated conditions 
were categorical independent variables (HROS/21day, HROS/42day, LROS/42day, 
PBS/42day; LROS/16 day, PBS/16day, LROS/MS, PBS/MS) (Table 4.2). The measured 
results were dependent variables. The measured 𝐶CwaN\Z^ (Y/N) and 𝐷CwaN\Z^ (Y/N) were 
dichotomous variables. The measured 𝑋𝑐, 𝑆5	and 𝑆4 were continuous variables. There 
was only one Y/N result for the each measured dichotomous variable in each condition, 
meaning there was no difference between Y and Y, or N and N when different conditions 
were compared. There was only one measured 𝑋𝑐 for each condition and therefore, 𝑋𝑐 
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was not statistically analyzed. There were three measured 𝑆5	and three measured 𝑆4 for 
HROS/21day, HROS/42day, LROS/42day, PBS/42day, LROS/16 day, PBS/16day and 
PC mesh samples. The impact of the independent variables on 𝑆5	and 𝑆4were analyzed 
using One-way ANOVA with Tukey’s post hoc.   
Table 4. 2. Variables and statistical analysis methods 
Mesh Independent Variables Dependent Variables Measures 
Statistical 
Analysis 
LP 
Different ROS concentrations 
(HROS/21day, HROS/42day, 
LROS/42day, PBS/42day) 
𝐶CwaN\Z^ (Y/N) 2 – 
𝐷CwaN\Z^ (Y/N) 3 – 
𝑋𝑐 1 – 
S 3 One-way ANOVA 
SP 
Different ROS concentrations 
(HROS/21day, HROS/42day, 
LROS/42day, PBS/42day) 
𝐶CwaN\Z^ (Y/N) 2 – 
𝐷CwaN\Z^ (Y/N) 3 – 
𝑋𝑐 1 – 
S 3 One-way ANOVA 
ESP 
Synergistic effect (LROS/16 day, 
PBS/16day, LROS/MS, PBS/MS) 
𝐶CwaN\Z^ (Y/N) 2 – 
𝐷CwaN\Z^ (Y/N) 3 – 
𝑋𝑐 1 – 
LROS/16 day, PBS/16day, PC S 3 One-way ANOVA 
 
Results 
Higher ROS concentrations did not result in greater PP mesh changes in surface 
appearance, oxidation, crystallinity, and stiffness (Figure 4.5). The synergistic effect of 
ROS and mechanical strains did not lead to greater PP mesh changes in surface 
appearance, oxidation, crystallinity and stiffness than either mechanism alone.  
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Figure 4. 5. Overview of measured results. 
  
FTIR 
Greater PP mesh surface oxidation was not related with higher ROS 
concentrations, as evidence of 𝐶CwaN\Z^ (N) for both LP and SP mesh samples in 
condition of HROS/42day, compared to 𝐶CwaN\Z^ (Y) in LROS/42day. PP mesh surface 
oxidation was not related with synergistic effect of ROS and mechanical strains, as 
evidence of 𝐶CwaN\Z^ (N) for ESP mesh samples in condition of LROS/MS, compared to 
𝐶CwaN\Z^ (Y) in LROS/16day.  
The FTIR spectra for three PC mesh samples was similar. Peaks at 1740 cm-1 or in 
the range of 3100 – 3600 cm-1 (𝐶CwaN\Z^ (Y)) were observed in LP mesh samples in 
conditions of HROS/21day and LROS/42day, in SP mesh samples in LROS/42day, and 
in ESP mesh samples in LROS/16 day compared to PC mesh samples (Figure 4.5). 
Although 𝐶CwaN\Z^ (Y) was observed in LP mesh samples in HROS/21day condition, 
LP SP ESP
HROS
21 DAY 
Different ROS Concentrations on PP Mesh Degradation Synergistic Effect
Csurface Y N N N Y N
Dsurface Y Y N Y Y N
Xc 50.3% 50.1% 47.6% 48.4% 54.1% 47.6%
Sx (N/cm) 127.2 ± 6.1 128.8 ± 16.0 86.2 ± 10.4 93.8 ± 10.1 104.2 ± 4.2 102.4 ± 7.1
Sy (N/cm) 141.6 ± 2.1 146.5 ± 12.3 172.5 ± 17.2 184.5 ± 15.0 180.7 ± 2.9 176.9 ± 15.4
HROS
42 DAY 
HROS
21 DAY 
HROS
42 DAY 
LROS 
16 DAY 
PBS 
16 DAY 
LROS
42 DAY 
PBS
42 DAY 
LROS
42 DAY 
PBS
42 DAY 
LROS/MS
16 DAY 
PBS/MS
16 DAY 
Csurface Y N Y N N N
Dsurface Y N Y N Y N
Xc 50.3% 48.2% 48.6% 48.0% 46.5% 47.5%
Sx (N/cm) 137. 6 ±14.6 138.4 ± 3.2 93.9 ± 10.9 90.9 ± 14.4 97.9 ± 1.8 108.9
Sy (N/cm) 146.6 ± 11.8 142.6 ± 3.9 183.4 ± 18.1 192.0 ± 31.9 177.8 ± 4.3 212.6 
Xc 48.3% 47.6% 49.4%
Sx (N/cm) 130.5 ± 5.5 90.3 ± 3.5 108.2 ± 12.4
Sy (N/cm) 136.8 ± 4.3 184.0 ± 13.7 176.8 ± 16.2
PC
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𝐶CwaN\Z^ (N) was observed in HROS/42day, confirming the instability of HROS on PP 
mesh degradation.  
No peaks representing PP degradation was observed for ESP mesh samples in 
condition of PBS/16day, confirming PP surface was stable at 50 °C (Figure 4.6). Silicon 
grease was observed for ESP mesh samples in LROS/MS and PBS/MS (Figure 4.6), 
which was used for sealing the simulators. The contamination was caused by the gravity 
and high temperature, dissolving the silicon grease into the solution, which interfered the 
FTIR readings due to its protection on PP surface from being oxidized.  
 
Figure 4. 6. FTIR results of SP and ESP mesh samples in different conditions. The FTIR 
reuslts for LP mesh samples were not included due to the same spectra as SP results. 
 
SEM 
The impact of different ROS concentrations on PP mesh surface appearance 
change was not detectable, due to the evidence of 𝐷CwaN\Z^ (Y) for both LP and SP mesh 
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samples in conditions of HROS/42day and LROS/42day (Figure 4.7). Similarly, the 
relation between PP mesh surface appearance change and synergistic effect of ROS and 
mechanical strains was not detectable, due to the evidence of 𝐷CwaN\Z^ (Y) for ESP mesh 
samples in both conditions of LROS/MS and LROS/16day (Figure 4.7).  
The surface appearance for three PC mesh samples was similar, with lack of 
surface damage recorded as 𝐷CwaN\Z^ (N). 𝐷CwaN\Z^ (Y) was observed for LP mesh 
samples in conditions of HROS/21day, HROS/42day and LROS/42day, for SP mesh 
samples in condition of HROS/42day and LROS/42day, and for ESP mesh samples in 
conditions of LROS/16 day and LROS/MS (Figure 4.5), confirming changes in the PP 
surface appearance was induced by ROS. 𝐷CwaN\Z^ (N) was observed for PBS/MS, 
confirming low mechanical strain (5%) did not affect PP surface appearance.  
The 𝐷CwaN\Z^ (Y) was in the form of small spots scattered on the surface, similar 
to mesh after reserialization (34), which was possibly induced by the heat released by the 
chemical reaction of H2O2 catalyzed with 0.05 M CoCl2. Although narrow surface 
cracking along the fiber direction was observed for all mesh samples, the cracking was 
not induced by oxidizing chemicals. Instead, similar cracking was observed in pristine 
mesh samples in other studies (24, 34).  
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Figure 4. 7. SEM results of SP and ESP mesh samples in different conditions. The SEM 
results for LP mesh samples were not included due to the same images as SP results. 
 
DSC 
PP mesh crystallinity was not related with different ROS concentrations due to the 
crystallinity of LP and SP mesh samples in all conditions within 5% range variation of 
PC mesh samples. PP mesh crystallinity was not related with synergistic effect due to the 
crystallinity of LROS/MS within 3% variation compared to PBS/MS (Figure 4.8).  
There was a trend for increased crystallinity for ESP mesh samples exposed to 
ROS and for decreased crystallinity for ESP mesh samples exposed to mechanical strains. 
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The crystallinity for ESP mesh samples exposed to LROS/MS (46.4%) was within 3% 
variation of PBS/MS (47.5%) and around 6% variation of PC mesh samples (49.4%), but 
more than 14% variation of LROS/16day (54.1%).  
 
 
 
Figure 4. 8. Crystallinity results of all mesh samples in all simulated conditions. Shaded 
area: within 5% variation compared to PC. There was only one measured 𝑋𝑐 for each 
condition. 
 
Mechanical Testing 
 ROS concentration was not a factor affecting mesh biaxial stiffness (One Way 
ANOVA, p > 0.05). Biaxial stiffness for both LP and SP mesh samples in conditions of 
HROS/21day, HROS/42day, LROS/42day and PBS/42day was not significantly different 
from stiffness for PC mesh samples (One Way ANOVA, p > 0.05) (Figure 4.9).     
There was a trend for decreased stiffness for ESP mesh exposed to ROS with or 
without mechanical strains (Figure 4.9). 𝑆4 of LROS/MS (97.9 ± 1.8 N/cm) was 10% 
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lower compared to PC mesh samples (108.2 ± 12.4 N/cm). The 𝑆5 of LROS/MS (97.9 ± 
1.8 N/cm) was 10% lower than LROS/16day (104.2 ± 4.2 N/cm) and 10% lower than 
PBS/MS (108.9 N/cm) and the 𝑆4	of LROS/MS (177.8 ± 4.3 N/cm) was 2% lower than 
LROS/16day (180.7 ± 2.9 N/cm) and 14% lower than PBS/MS (212.6 N/cm) and. Biaxial 
stiffness for ESP mesh samples in condition of LROS/16day and PBS/16day was not 
significantly different from PC mesh samples (One Way ANOVA, p > 0.05), confirming 
stable mesh stiffness in case of ROS at 50 °C. 
 
 
Figure 4. 9. Stiffness results of all mesh samples in all simulated conditions. There was 
only one measured stiffness for PBS/MS condition.  
 
Discussion 
In this study, PP mesh material changes after exposed to different ROS 
concentrations were compared and the synergistic effect of ROS and mechanical strains 
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on PP material changes was estimated. PP mesh changes in surface appearance, 
oxidation, crystallinity, and stiffness were not related with higher ROS concentrations. 
The synergistic effect of ROS and mechanical strains was not related with greater PP 
mesh changes in surface appearance, oxidation, crystallinity and stiffness compared to 
either mechanism alone. The unexpected results were likely due to lower reactive oxygen 
radicals on the PP mesh surface, low depth of surface oxidation, amorphous region 
recrystallization, relatively low mechanical strains and insufficient degradation time.  
It was suspected that lower reactive oxygen radicals on the PP surface in 
simulated high ROS solutions limited the PP mesh oxidation. PP oxidation was initiated 
by hydroxyl radicals and reacted with soluble oxygen to create hydroperoxide radicals, 
which reacted with C-H bond in PP backbone to form hydroperoxide (-COOH), leading 
to PP chain scission (26). The reactive hydroxyl radicals and oxygen were created by 
Haber-Weiss reaction of H2O2 and CoCl2 (26, 28). The constant 0.05M CoCl2 was used 
for high and low ROS solution to avoid decreased oxygen solubility caused by increased 
CoCl2 due to the salting out effect (35). Although the original solubility of oxygen was 
the same for both high and low ROS solutions, 6.52 M H2O2 reacted more actively than 
1.63 M H2O2, releasing heat that decreased the oxygen solubility. Without enough 
oxygen, it can be difficult to create hydroperoxide radicals and the oxidation process was 
terminated.  
There were contradictory results of decreased PP stiffness and increased 
crystallinity for mesh exposed to ROS and increased PP stiffness and decreased 
crystallinity for mesh exposed to mechanical strains in the study of the synergistic effect. 
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One possible explanation is the recrystallization of small fractions and low depth of 
oxidation on PP mesh surface (28, 36). PP mechanical properties were influenced by the 
amount of and the orientation of crystalline regions. When PP oxidation due to chain 
scission occurred in the amorphous region with short chains, the recrystallization of the 
short chains led to increased crystallinity (36). When chain scission occurred in both 
amorphous and crystalline regions, there were no changes observed for mesh 
crystallinity. However, when the recrystallized regions were not along the PP fiber 
direction, PP stiffness was decreased. The depth of surface oxidation on PP mesh induced 
by H2O2/CoCl2 was controlled by the diffusion rate, concentrations of hydroxyl radicals 
and oxygen, and duration (28, 37). It was possible that the experimental duration in this 
study was not long enough to create deep surface cracks for propagating into bulk 
degradation to achieve both decreased crystallinity and stiffness.  
The small mechanical strains (~5%) and short degradation times used for the 
synergistic effect study were unable to generate greater PP degradation than each factor 
alone. Previous studies report a synergistic effect on poly (etherurethane urea) or 
polyurethane degradation within 2 weeks of applied strains up to 300% ~ 400% (25, 27). 
In the current synergistic effect study, the applied mechanical strains were maintained by 
air pressure at 1.6 ± 0.2 psi to generate a membrane stiffness within a physiological 
stiffness range (29). The resulting 5% mechanical strains induced tension in the PP mesh 
up to 3 N/cm, lower than the estimated static load of 7.5 N/cm for implanted hernia mesh 
(1). Previous studies also observed a synergistic effect of PLGA degradation with applied 
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strains up to 0.1% after 5 weeks (38). The degradation duration in the current study was 
only 16 days, considerably shorter than 5 weeks (26). 
An experimental protocol for in vitro study of the synergistic effect of ROS and 
biaxial mechanical strains was developed and validated by these preliminary results. In 
future studies, it is recommended that the simulated ROS solution concentration should 
be 1.63 M H2O2/ 0.05 M CoCl2 (25) and the recommended mechanical strains should be 
at least 10% for ESP mesh samples to simulate the static load of 7.5 N/cm for implanted 
hernia mesh (1). This may not be possible using the current design of the abdominal wall 
simulator and alternative approaches should be considered. The recommended incubation 
time for the system is at least 5 weeks before material characterization (26, 38).  
Conclusion 
A preliminary experimental protocol for in vitro simulation of the synergistic 
effect of ROS and biaxial mechanical strains was developed. The initial simulation did 
not lead to greater changes in surface appearance, oxidation, crystallinity and stiffness for 
PP mesh exposed to both mechanisms compared to either mechanism alone. Compared to 
hernia meshes, implanted pelvic meshes are exposed to higher tension. Additional studies 
are recommended using increased mechanical strains and longer incubation to further 
explore these synergistic mechanisms that potentially contribute to the failure of pelvic 
meshes. 
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CHAPTER FIVE 
 
SURFACE MODIFICATION OF POLYPROPYLENE SURGICAL MESHES FOR 
IMPROVING ADHESION WITH POLOXAMINE HYDROGEL ADHESIVE 
 
 
Introduction 
Polypropylene (PP) is commonly used as sutures and grafts, such as surgical 
mesh, due to its long-term structural stability and low tissue response (1). In hernia 
repair, PP meshes are usually fixed to abdominal tissue by sutures, staples, tacks or tissue 
adhesive, such as fibrin glue and synthetic adhesive (2, 3). Tissue adhesive has notable 
clinical benefits compared with other methods (3). However, fibrin glue has inadequate 
tensile and adhesive strengths compared to sutures or synthetic adhesives (4). In contrast, 
synthetic adhesives have mechanical properties suitable for repairing defects in tissues 
exposed to high tensile loads, such as the bladder and abdominal wall (4-9).  
Thermosensitive hydrogels are widely used in commercially available medical 
products, including drug delivery systems, wound dressings, and 
tissue engineering scaffolds (10-12). They can be fabricated from a variety of common 
polymers that provide beneficial properties such as biodegradation, flexibility, and 
fast gelation (12). In the present study, a bifunctional poloxamine hydrogel adhesive that 
consists of a modified four-arm poly (propylene oxide)-poly (ethylene oxide) (PPO-PEO) 
block polymer and a thiol crosslinker was selected for testing (7, 8). This hydrogel-based 
tissue adhesive was previously shown to exhibit adhesive strength that exceeds 70 kPa 
via mechanical interdigitation and covalent bond formation with tissue amines (7-9). 
However, when this hydrogel adhesive was tested with different types of PP mesh, the 
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adhesive strength ranged from 10 kPa to 61 kPa (13), which was lower than the adhesive 
strength for collagen tissues (7). It was speculated that the adhesive strength was limited 
by the hydrophobicity of PP monofilaments and lack of covalent bond formation (13). 
Thus, we hypothesized that surface modifications of PP mesh with introduction of serum 
proteins might improve the adhesive strength by achieving covalent bonds.  
Two surface modification techniques have potential for this application. A 
common surface modification for PP is protein adsorption achieved through hydrophobic 
and van der Waals interactions (14). In this manner, hydrophobic regions in the proteins 
and the PP surfaces interact, which leaves the hydrophilic regions away from the PP 
surface, and it is suspected that the non-polar surface chemistry of PP monofilament will 
lead to the poor protein adhesion. Another surface modification technique involves 
grafting permanent covalent functional groups onto materials to form a protein coating 
(15, 16). Poly-glycidyl methacrylate (PGMA), which contains an epoxy group in each 
repeating unit, can be used as an anchoring layer for grafting on the surface of medical 
devices (15, 17, 18). The PP surfaces of mesh can be activated with plasma to provide 
radicals and these radicals react with water, forming functional groups for depositing the 
PGMA layer. The PGMA layer has epoxy functionalities that reacts with human serum 
albumin (HSA) to form a three-dimensional plastic albumin.   
The purpose of the current study was to use two different surface modifications of 
PP mesh to improve the adhesive strength between poloxamine hydrogel adhesive and PP 
mesh by achieving both mechanical interlock and covalent bonds. It was hypothesized 
that the adhesive strength between the poloxamine hydrogel adhesive and modified PP 
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mesh is stronger than the adhesive strength between the poloxamine hydrogel adhesive 
and unmodified PP mesh.  
Materials and Surface Modification 
Mesh Samples 
Two commercially available heavyweight (HW) (Bard® Composix® Kugel® 
Hernia Patch and lightweight (LW) (Bard Composix L/P Mesh, Davol Inc, Warwick, RI, 
USA) warp knitted meshes were selected (Table 5.1) (19-21). The LW mesh has large 
pore size to facilitate tissue ingrowth and incorporation. The meshes were composed of 
two layers: PP warp knitted mesh structure and submicron e-PTFE membrane. PP for 
surgical mesh is a hydrophobic material with desirable properties of flexibility, chemical 
resistance and thermal stability. The e-PTFE membrane acts as a barrier layer to 
minimize the tissue adherence to PP mesh. Since the tissue adhesive is only applied 
between the PP mesh side and the abdominal wall tissue during surgery, the e-PTFE 
layers were removed and only the PP meshes were investigated in this study (6, 22, 23). 
Sample meshes were cut at dimension of 1 cm × 3 cm, to match the aluminum holders 
used for lap shear testing (ASTM F2255-05). 
Table 5. 1. Polypropylene mesh information and surface modification techniques 
Mesh 
Type Classification Structure 
Weight 
[g/m2] 
Thickness 
[mm] Porosity Surface Modification 
HW Standard Class III 
 
95 0.57 Area: 57% Weight: 83% 
PGMA/HSA grafting 
BSA adsorption 
None 
LW Light Class III 
 
41 0.48 Area: 64% Weight: 90% 
PGMA/HSA grafting 
BSA adsorption 
None 
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Bifunctional Poloxamine Hydrogel Adhesive 
Two polymers used for bifunctional poloxamine hydrogel adhesive were 
synthesized from Tetronic® 1107 (T1107, molecular weight: 15k Da, HLB:18-23) 
(BASF corporation, Florham Park, NJ) following the published methods (7-9). The 
polymers were acrylated T1107 and acrylated T1107 with the addition of N-
hydroxysuccinimide (NHS). The acrylation (ACR) process was used to chemically 
crosslink the polymer within the hydrogel and the NHS process facilitated binding to the 
tissue amines (8). In the ACR process, the hydroxyl groups at the end of each four arms 
of T1107 were reacted with acryloyl chloride (Sigma-Aldrich) to form T1107-ACR with 
acrylate end groups (Figure 5.1). In the NHS process, the NHS groups (Sigma-Aldrich, 
St. Lois, MO, USA) were added to partially acrylated T1107 with 50% acrylation to form 
T1107-ACR-NHS (Figure 5.1). The composition of T1107-ACR and T1107-ACR-NHS 
was assessed by Proton NMR in d-chloroform.  
The bifunctional poloxamine hydrogel solution was made with the final 
concentration of 30 wt% mixture of 75 wt% T1107-ACR (ACR conversion: 92%) and 25 
wt% T1107-ACR-NHS (ACR conversion: 30%). The bifunctional poloxamine hydrogel 
adhesive was processed by crosslinking the hydrogel mixture with dithiothreitol (DTT) 
(Across Organics, NJ, USA). This thiol donor crosslinker, was added using the process of 
Michel-Type addition reaction in 1x Phosphate Buffer Saline (9). The molar ratio of thiol 
to acrylate in this adhesive solution was 1:1. Tetronic® 1107 is thermosensitive in water. 
The thermal gelation temperature of poloxamine hydrogel adhesive was at room 
temperature (7). When the concentration and/or the temperature is above its critical 
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micellar concentration and critical micellar temperature, the aqueous solution becomes a 
hydrogel. Therefore, this bifunctional poloxamine hydrogel adhesive was kept at 4 °C 
before use.  
 
Figure 5. 1. Tetronic® T1107 (A) acrylation reaction (B) N- hydroxysuccinimide (NHS) 
reaction.  
T: Tetronic® T1107, DCM: Dichloromethane (HPLC grade), TEA: trimethylamine, 
THF: tetrahydrofuran, DMAP: 4-dimethylaminopyridine, EDC: 1-(3-
dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (9). 
 
Surface Modification 
PP for surgical mesh is a hydrophobic material with low surface energy and lack 
of functional groups, which makes it difficult to strongly adhere layered coatings of 
another material. Two surface modification methods (BSA adsorption and PGMA/HSA 
grafting) were compared in this study. The BSA adsorption involved immersing PP 
meshes in 5% (w/v) bovine serum albumin (BSA) (Sigma-Aldrich) (PH = 7.4) in PBS 
buffer at 37°C for 30 minutes (14, 24). Samples were air dried at room temperature 
before applying poloxamine hydrogel adhesive. The PGMA/HSA grafting involved 
fabrication of an albumin coating (15) (Figure 5.2a). Mesh samples were treated under 
plasma for 10 minutes at 700 V DC, 15mA DC, 10.5 W (Plasma Cleaner / Sterilizer, 
Harrick, Pleasantville, NY) followed by soaking in water for 30 minutes to activate the 
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PP surface with hydroxyl, carboxylic acid and nitric oxide functional groups. After 30 
minutes, samples were oven dried (~80 °C) and purged under nitrogen until fully dried. 
Plasma treated PP mesh samples were dip coated (Meyer Fientechnik, Gottingen, 
Germany; D-3400) in 0.5% (w/v) PGMA (Mn= 176000g/mol) in chloroform at the speed 
of 300 mm/min. PGMA modified samples were annealed at 120 °C for 10 minutes 
followed by dip coating in 3% (w/v) human serum albumin (HSA) (Sigma-Aldrich corp., 
St. Louis, MO; CAS # 7024-90-7) solution in phosphate buffer for 2 hours. The 
PGMA/HSA grafted samples were dried for 12 hours and followed by annealing for 2 
hours at 120 °C. Unmodified PP meshes (HW & LW) were used as control groups (Table 
5.1). 
 
Figure 5. 2. Schematic diagram for surface modification methods. a. PGMA/HSA surface 
modification method. Modified mesh samples were annealed at 120 °C. b. BSA surface 
modification. 
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Testing Methods 
Thermo-gravimetric analysis (TGA) 
Unmodified LW and HW mesh samples were analyzed for thermal stability using 
TGA (TGA Q5000 V3.17 Build 265, TA Instruments, New Castle, DE) with a ramp rate 
of 10 °C/min from 25 °C to 600 °C in nitrogen gas. Samples were equilibrated at room 
temperature under nitrogen purge for 10 min prior to heating. 
Infrared Spectroscopy (FTIR) 
The bonding strength between BSA on the BSA modified PP and between the 
PGMA and HSA on the PGMA/HSA modified PP surface was confirmed by ATR-FTIR 
analysis (Nicolet Magna 550 FTIR spectrometer equipped with a SpectraTech Endurance 
Foundation Series Diamond ATR, Thermo, Waltham, MA). Unmodified PP filaments 
from unmodified meshes were used as control groups. Prior to FTIR, the BSA modified 
PP and PGMA/HSA modified PP were rinsed in ultrapure water. In order to remove any 
HSA that was not covalently bonded to the PGMA, the PGMA/HSA modified samples 
were washed by immersing in phosphate buffer at 37°C and pH7.4 on an orbital shaker 
for 24 hours.   
Contact Angle  
Static water contact angle of BSA modified, PGMA/HSA modified, and 
unmodified meshes was measured using optical contact angle goniometer (DSA‐20E, 
FM40Mk2 EasyDrop, Krüss, Germany) to measure the hydrophilicity of the samples. In 
a controlled environment (humidity: 35%, temperature: 25.4 °C), droplets of water (2.0 
µl) (n = 5) were placed on the edge of meshes. Although the software could automatically 
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measure the contact angle, the mesh knitting structures led to uneven surface, which 
decreased the accuracy of the automatic contact angle result. The final contact angle was 
measured manually using Image J (National Institutes of Health).  
Lap Shear Testing 
Adhesive strength, defined as the peak load under uniaxial lap shear testing 
divided by the contact area between the mesh and adhesive, was measured consistent 
with ASTM F2255-05 completed at 37°C using a 100 N load cell (Synergie 100, MTS, 
Eden Prairie, MN) at a 10 mm/min loading rate. The testing specimen was formed by two 
pieces of 1cm × 3cm aluminum holders adhered with collagen sheets (as tissue layers) 
and PP meshes (n=5 each), separately. A 60 µl volume of poloxamine hydrogel adhesive 
was applied over a 1cm × 1cm contact area between the mesh and collagen surface 
(Figure 5.3). The curing time for hydrogel adhesive was 1 hour. Samples were covered 
by a cloth containing PBS to maintain moisture. Test groups included BSA modified 
mesh, PGMA/HSA modified mesh, and unmodified meshes and tissue layers as controls.  
 
Figure 5. 3. Specimen for lap shear testing. 
 
Optical Microscope Images of Mesh Surface before and after Lap Shear Testing 
Individual mesh surfaces before and after lap shear testing were observed under a 
stereo optical microscope (SMZ-168, Motic, Richmond, Canada) with an attached digital 
camera (Infinity 2, Lumenera, Ottawa, Canada). Images were captured under 12 x with 
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0.243 pixel/cm at dimension of 1392 × 1040 with light projecting from bottom. Meshes 
modified with PGMA/HSA were investigated and unmodified meshes were used as 
control groups.  
Statistical Analyses 
The effect of mesh type (LW, HW) and surface modification method (BSA 
adsorption, PGMA/HSA grafting, unmodified) on adhesive strength was compared with 
two-way analysis of variance (ANOVA) (α=0.05). The differences between the surface 
modification techniques and individual mesh types were identified by Tukey’s post-hoc 
multiple comparisons (α=0.05). The effect of surface modification (PGMA/HSA grafting 
and unmodified) on contact angle was compared with paired t-test (α=0.05). The 
statistical analyses used OriginLab 9.0 (Northampton, Massachusetts, USA). 
Results 
TGA  
The thermal stability of the LW and HW PP meshes was well above the 120 °C 
annealing temperature used in the PGMA/HSA grafting process, with similar behavior 
for both mesh types (Figure 5.4).  
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Figure 5. 4. The weight loss (TGA curves, mass %) and the rate of weight loss (derivative 
thermogravimetry curves (DTG), mass %/°C) of unmodified HW and LW meshes.  
Green solid line: TGA curve for lightweight mesh, red solid line: TGA curve for 
heavyweight mesh, blue dashed line: DTG curve for lightweight mesh, black dashed line: 
DTG curve for heavyweight mesh. 
 
FTIR 
Chemical bonding between the albumin and PP was confirmed with FTIR, with 
PGMA/HSA successfully grafted onto the PP monofilament (Table 5.2). For PP mesh 
modified by BSA adsorption, the BSA was easily removed during routine rinsing, 
demonstrating poor protein adhesion on the PP monofilaments. This loss of BSA was 
confirmed by FTIR spectra having only a weak absorbance signal between 3300–3500 
cm-1 and around 1600 cm-1 (Figure 5.5). In contrast, the epoxy groups in PGMA assisted 
HSA protein adhesion to the PP. The presence of PGMA is evident by absorbance around 
1730 cm-1 (stretching of C=O groups) (25). The conversion of epoxy groups in PGMA is 
evident by the decrease of absorbance around 910 cm-1. The presence of HSA is evident 
by absorbance at 1541 cm-1 (amide II C-H stretching and N-H bending), around 1653 
cm-1 (bending of N-H groups) and absorbance from 3300-3500 cm-1 (stretching of amide 
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A N-H groups), which was not observed in unmodified PP (26-30). There was no 
difference in wave number peaks comparing before and after washing in phosphate buffer 
(Figure 5.6).  
Table 5. 2. Functional groups in FTIR wavelength 
Bond  Wavenumber (cm-1) References 
PP 
C–H3 and –CH2– 
 
2990 – 2850 
1380 – 1370 
1475 – 1450 
1465 – 1440 
 
(13) 
PGMA 
C=O 
 
1530 – 1830 
 
(22, 27) 
C–O 1240,1270      C–O–C stretching 1189, 1141 
Albumin 
Amide A NH stretching 
 
3300 
 
(24-26) 
Amide I band 
β sheet 
random coil 
α helix 
β-turn structure 
1600 – 1700  
1610 – 1640 
1640 – 1650  
1650 – 1658 
1660 – 1700  
 
Amide II band 1500 – 1600   
Amide II CH stretching and NH bending 1541  
 
 
Figure 5. 5. FTIR spectra of heavyweight and lightweight meshes modified by BSA. 
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Figure 5. 6. FTIR spectra of unmodified mesh, heavyweight, and lightweight meshes 
modified by PGMA/HSA before and after phosphate buffer washing. 
 
Contact Angle 
The hydrophilicity of meshes after surface modification was unchanged compared 
to unmodified meshes. The values of contact angles were larger than 110° for all types of 
meshes, consistent with the hydrophobic properties of the PP monofilaments (Figure 5.7). 
The meshes modified by PGMA/HSA (113 ± 6.02° for lightweight mesh and 129 ± 5.16° 
for heavyweight mesh) had smaller contact angles than unmodified meshes (128 ± 9.14° 
for lightweight mesh and 138 ± 9.01° for heavyweight mesh). However, the difference 
was not statistically significant (paired t-test, a = 0.05). 
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Figure 5. 7. Contact angle images of heavyweight and lightweight meshes before and 
after PGMA/HSA modification.  
U: unmodified, H: heavyweight, L: lightweight 
Paired t-test of contact angle before and after surface coating: p = 0.05. 
 
Lap Shear Testing 
The PGMA/HSA surface modification improved the adhesive strength for HW 
and LW meshes attached with poloxamine hydrogel tissue adhesive compared to 
unmodified meshes (Figure 5.8, Table 5.3). Mesh type was not a factor affecting the 
adhesive strength (two-way ANOVA, p = 0.075), but surface modification significantly 
affected the adhesive strength (two-way ANOVA, p < 0.01). The adhesive strength 
between unmodified meshes (44.95 ± 20.16 kPa for heavyweight mesh, 21.69 ± 8.642 
kPa for lightweight mesh) and tissue layers was significantly lower than tissue layers 
alone (Tukey, p < 0.05). The adhesive strength of meshes modified by PGMA/HSA 
(69.63 ± 30.93 kPa for heavyweight mesh, 65.25 ± 16.30 kPa for lightweight mesh) was 
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significantly higher compared to unmodified meshes and meshes modified by BSA 
(Tukey, p < 0.05) and equivalent to tissue layers alone (Tukey, p > 0.05). Therefore, the 
PGMA/HSA surface modification significantly improved the adhesive strength for 
meshes attached with poloxamine hydrogel tissue adhesive.  
Table 5. 3. Statistical analysis of lap shear testing strength with factors of mesh type and 
surface modification method  
Adhesive strength (kPa) Surface Modification Collagen Unmodified BSA PGMA/HSA 
Collagen            66.59 ± 25.26 Collagen -- * * p > 0.05 
UH                    44.95 ± 20.16 Unmodified  -- *  
* 
UL                    21.69 ± 8.642  
H-BSA              13.29 ± 4.378 BSA   -- * L-BSA              4.053 ± 0.8463   
H-PGMA/HSA   69.63 ± 30.93 PGMA/HSA    -- L-PGMA/HSA   65.25 ± 16.30    
*: Tukey’s post-hoc, p < 0.05 
 
Figure 5. 8. Adhesive strength between mesh and tissue under uniaxial lap shear testing. 
UH: unmodified heavyweight mesh, UL: unmodified lightweight mesh, H-BSA: 
heavyweight mesh modified by BSA, L-BSA: lightweight mesh modified by BSA, H-
PGMA/HSA: heavyweight mesh modified by PGMA/HSA, L-PGMA/HSA: lightweight 
mesh modified by PGMA/HSA. 
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Discussion 
This study evaluated two surface modification techniques (BSA adsorption and 
PGMA/HSA grafting) applied to PP mesh to improve the adhesive strength when 
attached to tissues using poloxamine hydrogel adhesive. The PGMA/HSA surface 
modification significantly improved the adhesive strength for meshes attached with 
poloxamine hydrogel tissue adhesive compared to unmodified meshes and meshes 
modified by BSA adsorption. The improved adhesive strength was achieved through 
mechanical interlock of the hydrogel tissue adhesive into the PP mesh pores and chemical 
bonding of the albumin after successful PGMA/HSA grafting onto the PP monofilament.  
Surface modifications of PP surgical mesh, including biologic coating materials 
such as gelatin, purified collagen and extracellular matrix, are commonly pursued to 
improve various mesh properties (21, 30-33). The coating should be applied on PP 
monofilament as a monolayer rather than allowing it to be trapped in mesh pores. A pore 
size of > 1 mm should be maintained to avoid scar plate formation on mesh instead of 
tissue ingrowth (34, 35). The spontaneous driving force during coating PP mesh without 
any other interactions is van der Waals force, which leads to inadequate coating stability. 
In previous studies, TiMesh light, a PP mesh coated with 30-50 nm hydrophilic titanium 
coating, tended to achieve better adhesion to tissue without further fixation than other 
polypropylene mesh (36). In contrast, the adhesive fixation strength of TiMesh with 
bioadhesive glue was lower than other polypropylene meshes with similar or larger pore 
size. This may be caused by a weaker interaction between polypropylene and titanium 
coating than the chemical bonds between titanium coating and the bioadhesive. In our 
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study, the fixation strength with poloxamine hydrogel adhesive for BSA- modified PP 
mesh was also lower than unmodified PP mesh. In aqueous solutions, the core of the 
protein is hydrophobic, whereas the outer edges are hydrophilic. Therefore, the BSA 
coating was mainly adsorbed onto the PP surface through van der Waals interaction. 
However, these interactions are notably weak, and adsorbed proteins can be separated 
from the PP surface when the interaction strength between the hydrophilic regions and 
the surrounding environment is larger than the hydrophobic and van der Waals 
interactions.  
Key aspects of the PGMA/HSA surface modification provided for strong 
chemical bonds between the PGMA/HSA coating and the PP surface and helped to 
prevent disruption of the coating during lap shear testing. In fact, Luzinov et al. (17, 37-
43) and others (44-47) clearly demonstrated that PGMA reacts with polymeric surfaces 
treated by air plasma and that proteins are readily reacting with epoxy groups of PGMA 
via amino and carboxyl functionalities. For instance, it was demonstrated using XPS that 
after enzymatic (protease) removal of fibrinogen or bovine serum albumin layers 
anchored to PGMA significant amount of amino acids remain grafted to the PGMA layer 
(37). During the surface modification process, the PGMA layer was first strongly 
chemically bonded through epoxy groups on the plasma activated PP surface. Further 
chemical bonds were formed between amino and carboxyl groups in albumin and 
remaining epoxy groups in PGMA, as confirmed by FTIR. The results from the current 
study support previous research using plasma treatment to improve the adhesion of 
functional groups and PGMA grafting to achieve strong covalent bonding between 
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hydrophobic PP mesh surfaces and the hydrophilic coatings (26, 30). Gorgieva, et al. 
activated PP mesh with O2 plasma to create functional groups on the PP surface, which 
further formed covalent bonds with a hydrophilic gelatin containing an antimicrobial-
active agent while maintaining the mesh structural and mechanical properties (30). The 
PGMA/HSA surface modification in the current study involved a “grafting to” method, 
with PGMA providing a uniform and homogeneous macromolecular anchoring layer 
(polymer brushes) for grafting polymers or proteins (e.g. HSA) to the PP surface (15-17). 
The PGMA epoxy groups are relatively stable at elevated temperature, which allowed for 
heat annealing and denaturation of HSA at 120 °C. PGMA polymer layers also can be 
deposited on various polymers, such as polyethylene terephthalate (PET), polyethylene 
(PE), PP, polyvinylidene fluoride (PVDF) and nylon (17).  
Adequate adhesive strength for PP mesh fixation is critical for repairing defects in 
abdominal wall tissues that are exposed to high tensile loads. Adhesive strength should 
reach the maximum tensile strength of the abdominal wall of 11 N/cm - 27 N/cm and the 
maximum intra-abdominal pressure of 22.8 kPa in healthy adults (36, 48). Using the 
approach of Schug-Pass, et al. and assuming a defect size of approximately 1 cm2 area, an 
abdominal pressure of 22.8 kPa would generate a force of approximately 2.28 N over the 
defect area (36). The necessary adhesive strength to resist this physiological force can be 
calculated by dividing by the contact area between the mesh and adhesive. In the current 
study, an area of 1 cm2 adhesive resulted in peak loads of 6.5-7 N during lap shear testing 
of meshes modified by PGMA/HSA (Figure 5.8), exceeding the maximum physiological 
levels. The mode of failure for this hydrogel adhesive is adhesive failure, caused by 
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detachment between adhesive and tissue (8). However, when the adhesive strength 
between adhesive and mesh is lower than that between adhesive and tissue, detachment 
occurs between adhesive and mesh. The large pores of PGMA/HSA modified samples 
after lap shear testing were filled with much more poloxamine hydrogel tissue adhesive 
than unmodified mesh (Figure 5.9) confirming strong chemical bonding and mechanical 
interlock are formed between PGMA/HSA modified mesh samples and hydrogel 
adhesive.  
In previous studies, fibrin glue or semi-synthetic adhesives have met the above 
physiological requirements, but have used much larger areas of adhesive on the mesh 
surface (6, 26, 36). For example, an area of 134 cm2 of fibrin glue was used to achieve a 
4.6-7.2 kPa adhesive strength for lightweight meshes in a ball burst set-up (36), which is 
below the 65 kPa average adhesive strength of LW meshes modified by PGMA/HSA in 
the current study (Figure 5.8). Moreover, the high viscosity of semi-synthetic adhesives 
prevents application over a large contact area during laparoscopic surgery (6). Synthetic 
cyanoacrylates adhesives have the advantages of fast fixation and adequate adhesive 
strength for hernia repair (4, 5), but in vitro cytotoxicity due to formaldehyde release and 
in vivo tissue toxicity have been reported (49).  
It is recognized that the nature of the abdominal wall affects the mechanical 
behavior of implanted surgical meshes in biaxial directions. A limitation of this study is 
that only uniaxial lap shear testing was used to assess adhesive strength. This method was 
selected because it is a common, highly repeatable method for generating adhesive 
strength results that are comparable to previous studies of this poloxamine hydrogel 
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adhesive (7-9). Moreover, existing biaxial testing procedures (e.g. ball burst test, clamp-
needle set-up) are insufficient for predicting the in vivo three-dimensional behavior of 
mesh. The ball burst test assumes uniform distribution of tension throughout all fibers 
within the mesh. However, the knitted structure of surgical mesh always behaves 
anisotropically (50, 51). Another limitation is the use of collagen to represent the tissue 
layer, which does not fully capture the complex biological aspects of the abdominal wall. 
In future studies, in vivo applications of PGMA/HSA modified PP mesh and hydrogel 
adhesive will be explored to characterize adhesion to tissues and any potential negative 
effects.  
 
Figure 5. 9. Hydrogel tissue adhesive residue on unmodified and PGMA/HSA modified 
mesh samples after lap shear testing.  
Unmodified mesh with minimal attached adhesive had pores without residue (bright 
white) and modified mesh with attached adhesive had pores with residue (gray). U: 
unmodified, L: lightweight mesh, H: heavyweight mesh. 
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Conclusion 
 In this study, successful PGMA/HSA grafting on PP mesh significantly improved 
adhesive strength with poloxamine hydrogel tissue adhesive compared to unmodified 
meshes and meshes modified by BSA adsorption. The experimental maximum adhesive 
strength for PGMA/HSA modified mesh was approximately 2 times higher than that of 
unmodified mesh, which was achieved by mechanical interlock of the hydrogel tissue 
adhesive into the PP mesh pores and chemical bonding of the grafted HSA. The 
application of PGMA/HSA grafting and hydrogel tissue adhesive would benefit both 
surgeons and patients in hernia mesh fixation in laparoscopic surgery. It provides for easy 
surgical handling due to fast gelation at body temperature and high adhesive strength, 
with the potential for reducing patient pain due to elimination of tissue penetrating using 
sutures or staples for mesh fixation.  
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CHAPTER SIX 
 
CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE STUDIES 
 
 
 The broad objective of this dissertation was to explore mechanisms of material 
changes in polymeric mesh implants after in vivo exposure using experimental 
characterization and biological assessments. This objective was addressed through 
completion of three aims by exploring specific mechanisms that potentially contribute to 
material changes after in vivo exposure using mesh explants (Aim 1) and in vitro 
simulation (Aim 2), and developing a new technology combining two patented 
technologies that improved clinical outcomes of hernia mesh fixation (Aim 3). Chapters 2 
and 3 addressed Aim 1, Chapter 4 addressed Aim 2, and Chapter 5 addressed Aim 3.  
Aim 1. Determine material changes of polymeric mesh explants and explore the 
mechanisms of material changes related to clinical factors  
Aim 1 was accomplished by comparing material properties of PP mesh explants 
to mesh implants before implantation to explore the impact of physiological function on 
potential degradation mechanisms of PP mesh related to clinical factors. Chapter 2 
compared pore size of explanted mesh to pristine mesh and related it to the pore pattern 
using a photogrammetric method. The photogrammetric method was developed using 
image capture, image processing and image analysis to classify pore pattern, measure 
pore size and evaluate changes in pore size after physiological loading. Chapter 3 
analyzed explanted PP mesh changes in surface chemistry, crystallinity and stiffness after 
mesh samples were sufficiently cleaned, and investigated clinical characteristics (i.e. 
mesh class, mesh placement location, patients’ infection record) that might trigger the 
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material changes consistent with PP degradation using analysis of multivariate 
associations. 
Recognizing pore pattern and the observed reduction in pore size in explanted 
meshes after supported in vivo reports of mesh shrinkage (1, 2). In general, smaller pores 
tend to remain unchanged whereas larger pores become smaller in explanted meshes 
compared with pristine control meshes. The photogrammetric technique developed in 
Chapter 2 used a simple light microscopy set-up and automated detection of pores, 
supporting efficient pore detection, providing for direct measurement of pore size area, 
minimizing human errors and avoiding errors when a symmetrical pore shape was 
assumed for a mesh with complicated pore shapes (3, 4).  
Evaluating explanted PP mesh material changes and their associations with 
clinical characteristics was important to explore potential mechanisms for PP mesh 
degradation when exposed to mechanical contraction or an oxidizing environment (5). 
The findings in Chapter 3 supported that infection (oxidizing environment) was a factor 
affecting stiffness changes and mesh class (pore size) was a factor affecting crystallinity 
changes when compared to pristine mesh, consistent with other in vitro and in vivo 
studies (6-8). Material changes were not associated with other clinical characteristics and 
the observed changes did not contribute to gross mesh failure. The universal application 
of significant findings in Chapter 3 was limited by the highly variable nature of implant 
retrieval analysis without controlled clinical and surgical factors for patient selection (9) 
and the small number of infection cases. The insignificant results were challenged by the 
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limited documentation of mesh selection at index surgery and it was unknown whether 
the PP mesh had absorbable components or fibers containing antioxidants.   
In future studies, there is a need for direct measurement of in vivo ROS (10) and 
in vivo mechanical strains (11) on mesh to help precisely establish the correlation 
between those factors and mesh degradation mechanisms. The direct measurement can be 
fulfilled using a controlled animal study with known mesh characteristics, such as 
antioxidants to modify ROS effects or absorbable components to modify mesh strains. 
Different from meshes implanted in the abdomen, pelvic floor surgical meshes are 
exposed to higher tension and have relatively greater risk of exposure to bacteria from the 
local environment (12), resulting in higher mechanical strains and accumulation of ROS 
due to the bacterial adherence. In a controlled animal study, different ROS concentrations 
and mechanical strain levels could be accomplished by implanting meshes in abdominal 
and pelvic locations. The findings in the controlled animal study can be used to estimate 
mesh degradation of hernia mesh explants and pelvic mesh explants removed from 
patients.       
Aim 2. Determine the effect of simulated oxidizing agents and applied mechanical 
strains on initiating polypropylene mesh degradation  
Aim 2 was accomplished by establishing the correlation between direct 
measurement of ROS and mesh degradation and estimating the synergistic impact of 
ROS and mechanical strains on PP mesh degradation, as evidenced by changes in surface 
appearance, oxidation, crystallinity, and stiffness using in vitro simulation. Chapter 4 
compared the PP mesh degradation induced by higher ROS concentrations to low ROS 
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concentrations and compared the PP mesh degradation induced by the synergistic effect 
of ROS and mechanical strains to either mechanism alone. 
The findings in Chapter 4 confirmed the simulated ROS solutions made of 1.63 M 
H2O2/ 0.05 M CoCl2 induced PP material changes (13) compared to higher ROS 
concentration. A preliminary experimental protocol for in vitro simulation of synergistic 
effect of ROS and biaxial mechanical strains was developed in Chapter 4. The simulation 
results rejected the hypothesis that the synergistic effect of oxidizing agents and 
mechanical strains significantly induced PP mesh degradation than the individual factors 
alone, which were likely due to low depth of surface oxidation and amorphous region 
recrystallization in case of inadequate mechanical strains and short degradation time.  
In future studies, there is a need to validate the simulation for synergistic effect of 
ROS and mechanical strains on PP mesh degradation and quantify the biaxial mechanical 
strains inducing PP mesh degradation. The simulation for synergistic effect can be 
validated using degradable materials requiring low applied mechanical strains (smaller 
than 5%) to induce material degradation. Different from degradable polymer materials, 
PP mesh is difficult to degrade under small mechanical strains (12, 14). The mechanical 
strains to initiate PP mesh degradation can be quantified using a biaxial tensile testing 
machine with adequate load cells. For a 2 cm ´ 2cm biaxial testing mesh sample, 100 N 
load cells are required to reach the estimated biaxial fatigue loads of 36.3 N/cm (12). A 
longer degradation duration, at least 5 weeks, should help to initiate PP mesh degradation 
(15, 16). 
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Aim 3. Determine the effect of surface modification of polymeric mesh implants on 
fixation and compatibility with a hydrogel adhesive  
Aim 3 was accomplished by comparing BSA adsorption and PGMA/HAS 
grafting of PP mesh to improve the adhesive strength with poloxamine hydrogel 
adhesive.  
The successful PGMA/HSA grafting onto PP monofilament in Chapter 5 
significantly improved adhesive strength through mechanical interlock of the hydrogel 
tissue adhesive into the PP mesh pores and chemical bonding of the albumin, compared 
to unmodified meshes and meshes modified by BSA adsorption. The maximum adhesive 
strength was up to 65–70 kPa for meshes modified by PGMA/HSA, compared to 4–13 
kPa for meshes modified by BSA, and 22–45 kPa for unmodified meshes using an area of 
1 cm2 adhesive. These results confirm the strong chemical bonds between the 
PGMA/HSA coating and the PP surface and helped to prevent disruption of the coating 
during lap shear testing (17). 
In future studies, there is a need for in vivo applications of PGMA/HSA modified 
PP mesh and hydrogel adhesive to characterize adhesion to tissues and any potential 
negative effects. Furthermore, there is a potential to apply the combined PGMA/HSA 
surface modification technique and hydrogel adhesive in other biomedical applications, 
such as “bio-adhesive biomaterial fixation system” in orthopedic applications, peripheral 
nerve regeneration and more.  
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Appendix A 
Patient Information for Chapter 2 
 
 
Table A- 1. Patient information (small pore mesh) 
Mesh # Sex (F/M) 
Age at 
removal 
(years) 
BMI Implantation time (months) 
Infection/ 
Smoker 
(Y/N) 
Removal reason/ 
Recurrent hernia 
(Y/N) 
M0004_14 M 55 40.7 13 N/N mesh not working/Y 
M0005_14 M 76 34.8 14 Y/N infection/Y 
M0010_14 F 58 24.7 42 N/N mesh not working/Y 
M0018_14 M 52 38.6 48 N/N mesh not working/Y 
M0035_14 M 59 31.8 12 N/N mesh not working/Y 
M0037_14 F 69 29.9 24 N/N mesh not working/Y 
M0039_14 M 65 35.7 60 N/N mesh not working/Y 
M0049_14 F 57 29.6 67 N/N mesh not working/Y 
M0054_14 F 67 36.6 48 N/N mesh not working/Y 
M0056_14 F 76 29.6 34 N/N mesh not working/Y 
M0063_14 M 41 27.4 5 N/N 
chronic 
inflammation, mesh 
not working/Y 
M0071_14 F 50 28.9 25 N/Y mesh not working/Y 
M0072_14 M 79 28.2 38 N/N bowel obstruction; mesh not working/Y 
M0077_14 M 74 23.7 10 N/N mesh not working/Y 
M0086_14 M 70 24.0 18 N/N mesh not working/Y 
M0091_14 M 34 31.6 11 N/N incarcerated, mesh not working/Y 
M0097_14 F 60 36.8 13 N/N mesh not working/Y 
 
 
Table A- 2. Patient information (large pore mesh) 
Mesh # Sex (F/M) 
Age at 
removal 
(years) 
BMI Implantation time (months) 
Infection/ 
Smoker 
(Y/N) 
Removal reason/ 
Recurrent hernia 
(Y/N) 
M0008_14 M 72 26.9 4 N/N mesh not working/Y 
M0021_14 F 82 27.3 8 N/N infection/Y 
M0038_14 M 59 29.9 6 N/N mesh not working/Y 
M0042_14 M 66 36.6 84 N/N mesh not working/Y 
M0044_14 M 73 26.8 20 N/N mesh not working/Y 
M0047_14 F 41 30.8 36 N/Y mesh not working/Y 
M0062_14 F 47 27.7 13 N/N seroma, mesh not working/Y 
M0091_14 M 34 31.6 11 N/N incarcerated, mesh not working/Y 
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Appendix B 
Mesh Orientation in Biaxial Tensile Testing 
 
 
Table B- 1. Mesh orientation in longitudinal (y) direction and transverse (x) direction 
Brand Microscope structure 
Orientation 
for biaxial 
tensile testing  
Brand Microscope structure 
Orientation 
for biaxial 
tensile testing  
Composix
Ô E/X 
  
Physiomesh
Ô (new 
structure) 
  
Composix
Ò KugelÒ 
  
Proleneâ 
Soft 
  
Composix
Ô L/P 
  
Ultraproâ 
  
C -QURÒ 
  
VentralightÔ 
  
The column of mesh orientation in biaxial tensile testing corresponds to the column of microscope 
structures  
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Appendix C 
Summary of Statistical Analysis for Chapter 3 
 
 
Table C- 1. Statistical analysis of mesh class on degradation 
Comparison n Statistical Test Result p value 
𝐶qwaN\Z^ and class 63 
Cochran-
Armitage Independent 0.30 
𝑋Z,Z[\]W^_%	and class 22, 23, 17 
One Way 
ANOVA 
Mean class I = (-2.5 ± 5.1)% 
Mean class II = (4.1± 6.0)% 
Mean class III = (1.8 ± 8.4)% 
0.004* 
𝑆5,Z[\]W^_%	and class 
 
 
𝑆4,Z[\]W^_%	and class 
11, 18, 6 One Way ANOVA 
Mean x, class I = -47.4 ± 24.4% 
Mean x, class II = -38.7 ± 21.2% 
Mean x, class III = -34.9 ± 25.9% 
Mean y, class I = -30.4 ± 35.7% 
Mean y, class II = -29.6 ± 19.9% 
Mean y, class III = -45.6 ± 24.5% 
0.49 
 
 
0.43 
mesh class: class 
*: p < 0.05 
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Table C- 2. Statistical analysis of patient factors on degradation 
Comparison n Statistical Test Result p value 
𝐶qwaN\Z^	and sex 63 Chi square Independent 0.53 
𝐶qwaN\Z^	and Timplantation  43, 16 Wilcoxon rank 
Median Y = 25 
Median N = 18 0.57 
𝐶qwaN\Z^	and age  46, 17 T test 
Mean Y = 59 ± 12 
Mean N = 58 ± 11 
0.69 
𝐶qwaN\Z^	and BMI 46, 17 T test 
Mean Y = 33.3 ± 6.7 
Mean N = 34.9 ± 5.8 
0.39 
𝑋Z,Z[\]W^_%	and sex 31, 31 Wilcoxon rank 
Median F = 1.6% 
Median M = 0.6% 0.70 
𝑋Z,Z[\]W^_%	and Timplantation 59 Spearman  ρ = -0.17 0.21 
𝑋Z,Z[\]W^_%	and age  62 Spearman ρ = 0.22 0.08 
𝑋Z,Z[\]W^_%	and BMI 62 Spearman ρ = -0.20 0.11 
𝑆5,Z[\]W^_%	and sex 
 
𝑆4,Z[\]W^_%	and sex 
17, 18 T test 
Mean x direction F = -34.6 ± 20.4% 
Mean x direction M = -16.6 ± 24.0% 
Mean y direction F = -28.9 ± 24.2% 
Mean y direction M = -36.1 ± 28.6% 
 
0.12 
 
0.43 
 
𝑆5,Z[\]W^_%	and Timplantation 
𝑆4,Z[\]W^_%	and Timplantation 
32 Pearson  r x = 0.14 r y= -0.10 
0.44 
0.57 
𝑆5,Z[\]W^_%	and age  
𝑆4,Z[\]W^_%	and age  
35 Pearson  r x = -0.10 r y = -0.17 
0.57 
0.33 
𝑆5,Z[\]W^_%	and BMI 
𝑆4,Z[\]W^_%	and BMI 
35 Pearson  r x = 0.25 r y = 0.14 
0.15 
0.42 
implantation time (months): Timplantation 
age at removal (years): age 
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Table C- 3. Statistical analysis of medical and surgical factors on degradation 
Comparison n Statistical Test Result p value 
Medical factors 
𝐶qwaN\Z^	and diabetes 62 Chi square Independent 0.92 
𝐶qwaN\Z^ and pre_her_re 62 Fisher’s exact Independent 0.76 
𝐶qwaN\Z^	and infection 61 Fisher’s exact Independent 0.42 
𝐶qwaN\Z^ and smoking 63 Fisher’s exact Independent 0.71 
𝑋Z,Z[\]W^_%	and diabetes 16, 45 Wilcoxon rank 
Median diabetes = 3.3% 
Median no diabetes = 0.9% 0.33 
𝑋Z,Z[\]W^_% and pre_her_re 43, 18 Wilcoxon rank 
Median pre_her_re = 2.1% 
Median no pre_her_re = -1.2% 0.33 
𝑋Z,Z[\]W^_%	and infection 8, 52 Wilcoxon rank 
Median infected = -1.6% 
Median noninfected = 1.5% 0.09 
𝑋Z,Z[\]W^_% and smoking 4, 58 Wilcoxon rank 
Median smoker = 2.1% 
Median nonsmoker = 1.5% 0.27 
𝑆5,Z[\]W^_%	and diabetes 
 
𝑆4,Z[\]W^_% and diabetes 
8, 26 T test 
Mean x, diabetes = -37.2 ± 29.4% 
Mean x, no diabetes= -41.0 ± 21.1% 
Mean y, diabetes= -32.9 ± 32.6% 
Mean y, no diabetes = -32.3 ± 25.5% 
0.69 
 
0.95 
𝑆5,Z[\]W^_%	and pre_her_re 
 
𝑆4,Z[\]W^_%	and pre_her_re 
21, 13 T test 
Mean x, pre_her_re = -37.9 ± 24.4% 
Mean x, pre_her_re = -43.8± 20.6% 
Mean y, pre_her_re = -31.6 ± 28.7% 
Mean y, pre_her_re = -33.8 ± 24.4% 
0.47 
 
0.82 
𝑆5,Z[\]W^_%	and infection 
 
𝑆4,Z[\]W^_%	and infection 
4, 30 T test 
Mean x, infection = -66.7 ± 13.4% 
Mean x, no infection = -36.6 ± 21.6% 
Mean y, infection = -64.9 ± 16.1% 
Mean y, no infection = -28.1 ± 25.0% 
0.01* 
 
0.01* 
𝑆5,Z[\]W^_%	and smoking 
 
𝑆4,Z[\]W^_% and smoking 
3, 32 T test 
Mean x, smoker = -40.4 ± 20.3% 
Mean x, nonsmoker = -40.7 ± 23.3% 
Mean y, smoker = -21.5± 23.0% 
Mean y, nonsmoker = -33.6 ± 26.8% 
0.98 
 
0.45 
Surgical factors 
𝐶qwaN\Z^	and intra_extra 62 Fisher’s exact Independent 0.16 
𝑋Z,Z[\]W^_%	and intra_extra 24, 37 Wilcoxon rank 
Median intra = 2.6% 
Median extra = 0.4% 0.74 
𝑆5,Z[\]W^_%	and intra_extra  
𝑆4,Z[\]W^_%	and intra_extra 
17, 17 T test 
Mean x, intra = -36.5 ± 20.0% 
Mean x, extra = -43.8 ± 25.5% 
Mean y, intra = -31.3 ± 24.6% 
Mean y, extra = -33.6 ± 29.5% 
0.36 
 
0.81 
previous hernia repair: pre_her_re 
mesh location: intra_extra 
*: p < 0.05 
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Appendix D 
Summary of Material Properties for Chapter 4 
 
Table D- 1. Summary of material properties 
 Proleneâ Soft ComposixÔ E/X 
 IR SEM Crystallinity (%) 
Stiffness 
(N/cm) IR SEM 
Crystallinity 
(%) 
Stiffness 
(N/cm) 
Different ROS Concentrations: 21 DAY 
High 
ROS Y Y 50.3% 
x: 127.2 ± 6.1 
y: 141.6 ± 2.1 N N 47.6% 
x: 86.2 ± 10.4 
y: 172.5 ± 17.2 
Different ROS Concentrations: 42 DAY 
High 
ROS N Y 50.1% 
x: 128.8 ± 16.0 
y: 146.5 ± 12.3 N Y 48.4% 
x: 93.8 ± 10.1  
y: 184.5 ± 15.0 
Low 
ROS Y Y 50.3% 
x: 137. 6 ±14.6 
y: 146.6 ± 11.8 Y Y 48.6% 
x: 93.9 ± 10.9 
y: 183.4 ± 18.1 
PBS N N 48.2% x: 138.4 ± 3.2 y: 142.6 ± 3.9 N N 48.0% 
x: 90.9 ± 14.4  
y: 192.0 ± 31.9 
Pristine 
   48.3% x: 130.5 ± 5.5 y: 136.8 ± 4.3   47.6% 
x: 90.3 ± 3.5  
y: 184.0 ± 13.7 
Synergistic Effect: 16 DAY 
Low 
ROS     Y Y 51.4% 
x: 104.2 ± 4.2  
y: 180.7 ± 2.9 
Low ROS + Strain   N Y 46.5% x: 97.9 ± 1.8  y: 177.8 ± 4.3 
PBS     N N 47.6% x: 102.4 ± 7.1  y: 176.9 ± 15.4 
PBS + Strain    N N 47.5% x: 108.9 y: 212.6 
Pristine 
       49.4% x: 108.2 ± 12.4  y: 176.8 ± 16.2 
 
